The Effects of Patient Education on the Recidivism Rate and Length of Stay of Clients with Schizophrenia by Parson, Mary Charlynne
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
Doctoral Dissertations Graduate School
5-2008
The Effects of Patient Education on the Recidivism
Rate and Length of Stay of Clients with
Schizophrenia
Mary Charlynne Parson
University of Tennessee - Knoxville
This Dissertation is brought to you for free and open access by the Graduate School at Trace: Tennessee Research and Creative Exchange. It has been
accepted for inclusion in Doctoral Dissertations by an authorized administrator of Trace: Tennessee Research and Creative Exchange. For more
information, please contact trace@utk.edu.
Recommended Citation
Parson, Mary Charlynne, "The Effects of Patient Education on the Recidivism Rate and Length of Stay of Clients with Schizophrenia. "
PhD diss., University of Tennessee, 2008.
https://trace.tennessee.edu/utk_graddiss/374
To the Graduate Council:
I am submitting herewith a dissertation written by Mary Charlynne Parson entitled "The Effects of
Patient Education on the Recidivism Rate and Length of Stay of Clients with Schizophrenia." I have
examined the final electronic copy of this dissertation for form and content and recommend that it be
accepted in partial fulfillment of the requirements for the degree of Doctor of Education, with a major in
Educational Administration.
Gary Ubben, Major Professor
We have read this dissertation and recommend its acceptance:
Ernest Brewer, Lloyd Davis, Lynn Ourth
Accepted for the Council:
Dixie L. Thompson
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)
To the Graduate Council: 
 
 
I am submitting herewith a dissertation written by Mary Charlynne Parson entitled “The 
Effects of Patient Education on the Recidivism Rate and Length of Stay of Clients with 
Schizophrenia.” I have examined the final electronic copy of this dissertation for form 
and content and recommend that it be accepted in partial fulfillment of the requirements 
for the degree of Doctor of Education with a major in Educational Administration and 
Policy Studies. 
 
      Gary Ubben, Major Professor 
 
 
We have read this dissertation 
and recommend its acceptance: 
 
 
Ernest Brewer 
________________________ 
 
Lloyd Davis 
________________________ 
 
Lynn Ourth 
________________________ 
 
 
         
Accepted for the Council: 
        
      Carolyn R. Hodges, 
 
Vice Provost and Dean of the Graduate 
School 
             
 
 
(Original signatures are on file with official student records.) 
 
 
 
 
 
 
 
 
 
 THE EFFECTS OF PATIENT EDUCATION ON THE RECIDIVISM RATE  
 
AND LENGTH OF STAY OF CLIENTS WITH SCHIZOPHRENIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Dissertation 
 
Presented for the 
 
Doctor of Education 
 
Degree 
 
The University of Tennessee, Knoxville 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Mary Charlynne Parson 
 
May 2008 
      
 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright ©  2008 by Charlynne Parson 
All rights reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii 
 
Acknowledgments 
 
Many family, friends, and colleagues have encouraged and assisted in the 
completion of this dissertation.  
Thanks go to the members of my committee from UTC, Dr. Lloyd Davis and Dr. 
Lynn Ourth and from UTK, Dr. Mary Jane Connelly and Dr. Ernest Brewer, and 
particularly to Dr. Gary Ubben, Chair, who made it all finally happen; to my husband, 
Maurice, and children, Brian and Kelly, who consistently and enduringly offered 
encouragement; my friends and co-workers, Patricia Alverson, Betty Gaines, and Judy 
Nance who were my best and most loyal cheerleaders; and Zeta Alpha Chapter, Sigma 
Theta Tau for resource assistance for the project. 
Special appreciation goes to my colleagues, Carole Abrahamson, Wanda Birdine, 
and Dr. Janet Secrest who tirelessly and selflessly gave me their time and expertise for 
data organization and interpretation. 
We are all happy it is over! 
 
 
 
 
 
 
 
 
 
 
 
 iv 
Abstract 
 
Schizophrenia is a complicated, serious mental illness that affects about 1% of the 
population. In addition to the behavioral issues they must contend with, the patients often 
have other problems including medical illness, substance abuse, noncompliance with 
treatment and medications, and those involving basic skills. The cost of treating this 
disabled population is very high, but patient education could be a cost-effective 
intervention to break the “revolving door” phenomenon of recidivism and 
rehospitalization. This study examined the readmission rate (recidivism), length of stay, 
and the intervals between admissions for 279 male and 183 female patients with chronic 
schizophrenia who either did or did not participate in psychosocial education over a nine 
(9) year period to determine whether there was a difference between the groups. The 
findings showed that both the number of patients and return rate (recidivism) for the 
years following the initial intervention was considerably lower for patients who had the 
educational intervention and the patients who had the educational intervention had longer 
intervals between admissions. However, due to uncontrolled-for confounding variables, 
the average LOS for the intervention group for 4 of the 8 years was greater than the 
control group.  
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Chapter 1 
Introduction 
Noncompliance with the prescribed treatment regimen is a major factor in 
readmission of patients to psychiatric hospitals. According to Surber, Winkler, 
Monteleone, Havassy, Goldfinger, and Hopkins (1987), the diagnoses most likely 
to produce recurrent psychotic episodes are schizophrenia, bipolar affective 
disorder, borderline personality disorders, and often substance abuse, although it 
is underreported. Indeed, Kosten and Douglas (1997) note that up to 50% of 
individuals with schizophrenia have either alcohol or illicit drug dependence and 
about 70% more are also nicotine dependent. Substance abuse among psychiatric 
patients, especially those with schizophrenia, worsens prognosis, increases the 
likelihood of noncompliance and institutionalization, chemical dependence, 
violent behavior, and suicide (Conley, 2000; Oster, Berbaum, & Patton, 2001; 
Ziedonis & Williams, 2002).   
 Additionally, psychiatric patients often present with an array of other 
problems, including behavioral and medical issues along with those involving 
basic living skills such as managing money and maintaining housing. It has been 
noted that as they age, patients with schizophrenia have greater risk than the 
general population of developing other illnesses such as type 2 diabetes 
(Goldman, 1999; Vieweg, Adler, & Fernandez, 2002). There is no doubt that 
mental illness complicates things for patients who are already having difficulty in 
communicating with caregivers due to their psychiatric symptoms. In some cases, 
the effects of psychotrophic drugs or substance abuse may complicate their 
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medical illness. Then, in others, the medical conditions may simply be overlooked 
because patients with schizophrenia have a high pain threshold and just don’t 
complain (Dixon, 2003; Dworkin, 1994; Goldman, 1999). Nevertheless, the cost 
of treating this disabled population is very high (Surber et al. 1987). 
 Platt, Tippy, and Turk (1994) report that poor compliance or nonadherence 
to treatment recommendations plague every aspect of medical practice. They note 
that only one-third of patients follow medical treatment and life style 
recommendations completely and correctly, and another third attempt to follow 
instructions, but do so incorrectly and the remainder completely fail to follow 
them. When Docherty (2003) compared medication compliance in a group of 
patients with physical disorders and those with psychiatric disorders (76% and 
58% respectively), he found that the mean compliance rate for the two groups to 
be less than 20% apart. Likewise, in a study of 113 multiple psychiatric admission 
patients, Carpenter, Mulligan, Bader, and Meinger (1985) found that 
noncompliance with medication was noted in 70% of the study group compared 
with only 38% of the comparison group who did not have multiple admissions. 
Sadly, the comprehensive review of recent literature that Lacro, Dunn, Dolder, 
Leckband, and Jeste researched in 2002, found that the nonadherence mean rate 
among patients with schizophrenia was still only close to 50%.  
In a review of the prevalence and risk factors for medication nonadherence 
in patients with schizophrenia, Lacro et al. (2002) identified the following factors 
associated with nonadherence: poor insight, negative attitude or subjective 
response toward medication, previous nonadherence, substance abuse, shorter 
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illness duration, inadequate discharge planning or aftercare environment, and poor 
therapeutic alliance. To these factors, Hudson et al., (2004) added patient reported 
barriers related to the stigma of taking medications, adverse drug reaction, 
forgetfulness, and lack of social support. Although, Docherty (2003) notes that 
partial compliance can’t be measured, it does affect the majority of patients and 
its impact includes decreased functionality, clinical worsening that is difficult to 
reverse, and relapse.   
Daumit, Crum, Guallar and Ford (2002) noted in their study of 
preventative care for patients with severe mental illness that there was a long-
standing separation of treatment for medical problems and mental illness. Even 
when primary care referrals are made, they are often given low priority by the 
patient because of more pressing concerns or lack of understanding of the 
benefits. Additionally, Montoya (2006) found that poor treatment compliance is 
often associated with blame for the patient and they may be involuntarily 
discharged from treatment. 
Appleby, Desai, Luchins, Gibbons, and Hedeker (1993) reported that 
psychiatric bed reductions in mental hospitals, particularly in public hospitals, 
have decreased 80% since 1955.  This reduction in beds has been achieved by 
shortening the length of stay by better than half what was reported ten years 
earlier. Appleby et al. (1993) in their study of 1,500 patients with schizophrenia 
who were tracked over and 18 month period, found that there was a linear relation 
between length of stay and relapse rates. They showed that patients hospitalized 
for short stays were more likely to return within 30 days of discharge and require 
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treatment for longer periods. Although brief stays may be consistent with the 
philosophy of deinstitutionalization, Appleby et al. (1993) feel that the evidence 
to support this practice is not beneficial to all patient groups. In fact, the advent of 
deinstitutionalization probably set the table for the mentally ill to not only swell 
the ranks of the nation’s homeless population (Miller, 2003); but to also move 
into the criminal justice system (Lamb & Weinberger, 1998). 
Rehospitalization rates tend to increase as a function of alcohol problems 
and medication noncompliance (Dhossche & Ghani, 1998; Haywood, Kravitz, 
Grossman, Cavanough, Davis, & Lewis, 1995). In their 2004, retrospective study 
of 4,325 California outpatients with schizophrenia being treated with 
antipsychotic medication, Weiden, Kozma, Grogg, and Locklear found that lower 
medication compliance was the most statistically significant risk factor associated 
with a higher risk of hospitalization. Given this strong association, Haywood, et 
al. (1995) emphasized the importance of patient education as a cost-effective 
intervention to break the cycle of what they called the “revolving door” 
phenomenon among the mentally ill. In 1997, Dixon, Weiden, Torres, and 
Lehman noted that the annual economic impact of schizophrenia noncompliance 
rehospitalization was around $800 million; however, by 2003, these costs had  
risen to between $33 to $65 billion (Cooper, Hanrahan, & Luchins, 2003; Marder, 
2002).  Perkins (2005) notes that 37% of this annual cost is related to treatment 
nonadherence.  Indeed, in today’s environment of less inpatient capacity, 
managed care and limits on reimbursement for hospital care, treatment must 
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emphasize concrete problem solving, education, and medication stabilization and 
compliance in order to be cost effective (Scheider & Ross, 2003). 
Platt et al. (1994) reviewed issues in patient nonadherence to treatment 
and lifestyle recommendations and found that patients usually benefit from 
knowing as much as possible about their illness or condition. They found that 
educational messages are more effective when provided by several sources and 
clearer when delivered verbally and reinforced by reading or listening materials. 
Indeed, Schaffer and Lopes (2003) believe that adherence is a learned behavior 
and can be improved with specific strategies directed toward improving adherence 
to the therapeutic regimen, practice by the patient, and reinforcement by 
healthcare providers. In her review of the impact that noncompliance has on the 
patient with schizophrenia, Perkins (2005) determined that improved drug 
delivery and behavioral interventions that reduce relapse and rehospitalization can 
also improve the patient’s quality of life and reduce treatment costs.   
In 1993, Birchwood, Mason, MacMillan, and Healy did an indepth study 
of the perception of controllability of illness in people with schizophrenia and 
manic-depressive illness. They found that patients who accepted their diagnosis 
reported that they felt they were able to exert control over their own health and 
this had an impact on compliance. Similarily, in their review of treatment 
compliance factors, Schaffer and Lopes, (2003) found that patients who are 
knowledgable about their disease and the treatments being used to manage it are 
also more motivated to adhere to the treatment plan. Even in field research 
involving rigorous controlled clinical research designs, Drake, Becker, and 
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Anthony (1994) determined that those clients who received information about the 
objectives of the study beforehand were facilitated in realistic decision making 
about vocational programs. The clients also reported enhanced satisfaction and 
there was decreased attrition from the study.  Likewise, more recently, Prince 
(2006) explored services to prevent rehospitalization within 3 months of inpatient 
discharge and found that providing specific interventions addressing symptom 
education, service continuity, and daily structure were most effective in assisting 
patients to stay out of the hospital. 
Problem 
 
Review of literature over the past twenty years suggested that a patient 
who is better informed can be more self-reliant after hospitalization, which would 
increase compliance and reduce the rate of readmission. We might ask whether 
patient self-management and improved compliance are products of group 
participation in patient education activities. If they are, then, will these group 
patient education activities make any difference in either the recidivism rate or 
length stay if the client does return to the hospital? 
Purpose 
The purpose of this study was to determine the effect that participation in 
patient psychosocial education activities while hospitalized has on readmission 
rates among patients with chronic schizophrenia.  
Research Questions 
 The specific research questions that guided the study were: 
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1. Do patients with chronic schizophrenia who receive psychosocial 
education have lower relapse rates (recidivism) than those who do 
not receive psychosocial education? 
2. Is there a difference between the length of stay for readmitted 
patients with chronic schizophrenia who have participated in the 
psychosocial education and those who have not? 
3. Is there a difference in the length of intervals between admissions 
for the group who had psychosocial education and the group who 
did not? 
 
Significance 
Of the research on the effects of patient education, few specifically target the 
patient with schizophrenia for study. Schizophrenia is a serious mental health 
problem. It affects roughly 1% of the population and has profound implications 
for our society, both in terms of human suffering and in prolonged, devastating 
financial costs (Horgan, 1990). In addition to hallucinations and delusions, the 
disease produces disorganization in thinking, depression, and diminished ability 
to function. In the United States, patients with this debilitating illness account for 
40% of all long-stay hospital days and they occupy 25%, of the beds available for 
all inpatient care (Kleyman & Rozenfeld, 2001). Costs linked to schizophrenia in 
this country account for 2.5% of our total healthcare expenditures (Perkins, 2005). 
This study compared the recidivism rate of patients with chronic schizophrenia 
who did and did not participate in psychosocial educational activities to see if 
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patient education made a difference in either the readmission rates interval 
between admissions, or length of stay for this diagnostic group.   
Most studies dealing with recidivism rates for mentally ill patients focus 
on either describing the type of patient likely to require readmission or the risk 
factors associated with the need for hospitalization. However, this study examined 
the impact of patient education for the client with chronic schizophrenia to 
determine whether there was a lower relapse rate between those who participated 
in the classes and those who did not.   
The findings in this study will be important because they will (1) provide 
information abut patient compliance that might be helpful in reducing recidivism 
rates, and (2) examine the value of psychosocial education in shortening the 
hospital stay for patients if readmitted. 
Delimitations 
The participants include only patients with the diagnosis of schizophrenia 
admitted to a medium sized state psychiatric hospital during the period of July 
1,1997, to June 30, 2006, who either participated in patient psychosocial 
educational groups designed to increase compliance with treatment after 
hospitalization or did not participate in such groups. Operational definitions for 
the following terms used in the study include:  
Schizophrenia - a medical diagnosis characterized by two (or more) of the 
following, each present for a significant portion of time during a 1 month period 
(or less if successfully treated): Delusions, hallucinations, disorganized speech 
(e.g., frequent derailment or incoherence), grossly disorganized or catatonic 
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behavior, and negative symptoms, i.e., affective flattening, alogia, or avolition.  
thinking, depression , and diminished ability to function. There are subtypes of 
schizophrenia that are defined by the predominant symptomatology (paranoid, 
disorganized, catatonic, undifferentiated and residual) at the time of evaluation 
(Diagnostic and Statistical Manual 4th Edition [DSM-IV], 2000). 
Paranoid Type (295.30) - a type of schizophrenia presenting with a 
preoccupation with one or more delusions or frequent auditory hallucinations. 
However, none of the following is prominent: disorganized speech or catatonic 
behavior, or flat or inappropriate affect (DSM-IV, 2000). 
Disorganized Type (295.10) - a type of schizophrenia in which 
disorganized speech, disorganized behavior, and flat or inappropriate affect are 
prominent. The criteria are not met for Catatonic Type (DSM-IV, 2000). 
Undifferentiated Type (295.90) - a type of schizophrenia in which 
symptoms that meet Criterion A (bizarre delusions and controlling 
hallucinations), are present, but the criteria are not met for the paranoid, 
disorganized, or catatonic type (DSM-IV, 2000). 
Residual Type (295.60) - a type of schizophrenia that presents with the 
absence of prominent delusions, hallucinations, disorganized speech, and grossly 
disorganized or catatonic behavior. There is continuing evidence of the 
disturbance through negative symptoms and two or more of the Criterion A 
symptoms for schizophrenia that present in the form of odd beliefs or unusual 
perceptual experiences (DSM-IV, 2000). 
  10 
Schizoaffective Disorder (295.70) – a type of schizophrenia characterized 
by an uninterrupted period of illness during which, at some time, there is either a 
Major Depressive Episode, a Manic Episode, or a Mixed episode concurrent with 
symptoms that meet criterion A for Schizophrenia: i.e., delusions, hallucinations, 
disorganized speech, grossly disorganized or catatonic behavior, and negative 
symptoms (DSM-IV, 2000).  
Psychosocial educational groups – formalized inpatient group educational 
sessions developed at UCLA Clinical Research Center for Schizophrenia and 
Psychiatric Rehabilitation. The groups, led by topic-specific educators, include 
four major components – social schemata, social skills, coping efforts, and social 
competence (Liberman et al. 1986). Educational groups in the study included 
symptom management,  medication management, anger and stress management, 
and leisure skills. The time for each group was limited to 20 minutes. Attendance 
was voluntary, but patients were encouraged to participate in the groups by the 
hospital staff. 
Recidivism - the readmission or rehospitalization rate by patients for 
treatment. 
 Global Assessment of Functioning (GAF) Scale (Appendix C) – a scale 
used by the psychiatrist to consider psychological, social, and occupational 
functioning on a hypothetical continuum on mental health-illness. It ranges from 
zero to one hundred points and considers dangerousness, impairment in judgment, 
behavior influenced by delusions or hallucinations, and degrees of social, 
occupational or school functioning. It is for reporting the clinician’s judgment of 
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the individual’s overall level of functioning at the time seen and can vary from 
day to day (DSM-IV, 2000). During the admission process, the physician assigns 
the diagnosis and GAF using the DSM-IV. There are 5 axes included in the DSM-
IV multi-axial classification, each of which refers to a different domain of 
information that may help the clinician plan treatment and predict outcome 
(Diagnostic and Manual of Mental Disorders, 2000). Clinical disorders such as 
schizophrenia are reported on Axis I while the assessment of functioning is on 
Axis V. Only two of the axes, diagnosis and GAF, are of concern for this study. 
Diagnostic and Statistical Manual 4th Edition (DSM-IV) – a resource 
manual used by the psychiatrist with established guidelines for making diagnoses. 
The DSM-IV provides clear descriptions of diagnostic categories of mental 
disorders to enhance agreement among clinicians.  
Limitations 
The study involved patients admitted to the state psychiatric hospital with 
the severe mental illness diagnosis of schizophrenia. It was confined to patients 
from a public psychiatric setting involved in formalized educational groups and 
those who were not in educational groups. All patients admitted to the facility met 
with their multidisciplinary team and agreed with the assignment to various group 
activities and formal education classes (e.g., symptom management, medication 
management, leisure skills, anger and stress management, and others). The most 
serious limitation was the lack of control over variables that were beyond the 
control of the researcher. Although comparative studies identify relationships, 
causation cannot be fully established since the data were retrospective and there 
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could be other uncontrolled variables that produced both the cause and the effect. 
Thus, generalizability of these findings must be approached with caution 
(Fraenkel & Wallen, 1996).  
Organization of the Study 
 This study was organized into five chapters. Chapter 1 contains 
background for the problem, purpose of the study, definition of terms, research 
questions, the significance of the study, limitations and delimitations, and 
assumptions. Chapter 2 includes a review of related literature, including the 
impact of Schizophrenia, the value of psychosocial education, and current 
research related to psychosocial education for persons with the diagnosis of 
Schizophrenia. Chapter 3 describes the methodology used in the study, including 
identification of the subjects, procedures for random selection, and procedures for 
conducting the study and interpreting the data. Chapter 4 includes the findings 
and interpretation of the data. Chapter 5 concludes with a summation of the 
findings and a discussion of the conclusions and implications for further research. 
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Chapter Two 
Review of the Literature 
 
Purpose of the Study 
 
The purpose of this study was to examine the relationship between 
readmission rates and participation in psychosocial education for patients with 
schizophrenia. The research approach was retrospective descriptive. The review 
was organized as follows: The impact of schizophrenia, the value of psychosocial 
education, and current research related to psychosocial education for persons with 
the diagnosis of schizophrenia. 
The Impact of Schizophrenia 
Schizophrenia is a serious mental health problem. It affects roughly 1% of 
the population in the United States and costs the nation $30 billion to $40 billion 
annually (Dixon et al., 2001; Horgan, 1990). Costs linked to schizophrenia in this 
country account for 2.5% of our total healthcare expenditures (Perkins, 2005). 
According to Surber et al., (1987), it is among the diagnosis most likely to 
produce recurrent psychotic episodes.   
Schizophrenia most often presents in early adulthood, but it can occur 
during any phase of life from childhood to old age (Kennedy, Jain, & Vinogradov, 
2001). The disease produces disorganization in thinking, depression, and 
diminished ability to function. It interferes with an individual’s ability to think, 
respond emotionally, behave appropriately, and interpret reality. The debilitating 
aspects of the illness result in social isolation, inability to maintain gainful 
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employment, incoherent or delusional thinking, and difficulty in managing life’s 
daily activities.   
Citrome (2004) notes that about one third of the patients with 
schizophrenia do not respond to typical antipsychotic agents and many more such 
patients can be expected to have only a partial response. In the United States, 
patients with Schizophrenia occupy 25% of the beds available for all inpatient 
care and account for 40% of all long-stay hospital days  (Citrome, 2004; Kleyman 
& Rozenfeld, 2001). Indeed, the impact that this disease has on individuals, 
families, and society is substantial. 
Diagnostic Criteria 
Pearlson (2000) notes that the clinical diagnosis of schizophrenia is 
determined by ruling out the possibility of other psychiatric and neurological 
disorders since it is based on behavioral observations and self-reported abnormal 
mental experiences for a period over at least six months (Kennedy et al., 2001). A 
chronic disorder, schizophrenia has periods of stability alternating with periods in 
which psychotic symptoms are prominent (van Meijel, Kruitwagen, van der Gaag, 
Kahn, & Grypdonck, 2006); but the actual etiology and pathogenesis of the 
disease is unknown. In fact, in their carefully controlled research study, Buckley 
and Buchanan (1999) were able to show a genetic linkage for schizophrenia on 
chromosomes 5, 6, 8, 13, and 22; however, they were unable to demonstrate 
evidence of a major genetic defect as the cause of schizophrenia. In family and 
twin studies, Craddock, O’Donovan, and Owen (2006) found that these same 
chromosomes show overlapping regions of interest in both schizophrenia and 
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bipolar disorder rather than purely for schizophrenia as was commonly held for 
over 100 years. Nevertheless, there are biochemical abnormalities and possibly 
neurodevelopmental issues; but regardless of the pathophysiology, current 
research asserts that it is most likely the interaction of both genetic and 
environmental factors that define the clinical presentation of the disorder (Dean, 
Keriakous, Thomas, & Scarr, 2005; Pearlson, 2000).  
The symptoms of schizophrenia are conventionally divided into “positive” 
and “negative” types. The positive symptoms are presumed to result from an 
excess or distortion of some normal neurophysiologic function, while the negative 
symptoms reflect a loss or diminution of normal function (Nasrallah & Smeltzer, 
2002). The positive symptoms of schizophrenia include hallucinations, delusions, 
thought disorders, disorganized speech, and bizarre behavior. Individuals also 
may experience co-morbid illnesses, such as depression or anxiety that may 
further compromise their levels of functioning. The negative symptoms include 
emotional flattening and social apathy; impaired judgment, problem solving 
ability, and abstract reasoning; poor initiative, motivation, and drive; lack of 
insight, difficulty in planning, and decreased concern for personal hygiene 
(Nasrallah & Smeltzer, 2002; Perkins, 2005). However, there are unexplained 
gender differences on both the risk and clinical expression of the disorder. 
 Women are more likely to experience more positive and affective 
symptoms, but have better treatment response while men have more negative 
symptoms, earlier onset, and a worse long-term outcome (Goldstein, 1997).The 
peak age of onset for males is between 15 and 25 years. Interestingly, onset in 
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women is delayed by approximately 3 to 5 years, possibly related to the protective 
role of estrogen (Nasrallah & Smeltzer, 2002; Seeman & Lang, 1990). However, 
after the age of 45 years, new cases in women surpass men by a ratio of 2:1 
(Nasrallah & Smeltzer, 2002; Seeman, 1996); but ultimately has the same 
male/female prevalence. Since schizophrenia shares a familial predisposition with 
several clinical syndromes, including schizoaffective disorder, schizotypal 
personality disorder, and probably psychotic affective illness, it suggests a genetic 
overlap between certain forms of affective illness and schizophrenia (Pearlson, 
2000). 
A small percentage of patients with schizophrenia have a single episode of 
acute illness with no residual impairment. However, while 30% of patients have a 
good outcome with minimal or no residual impairment, another 30% have 
moderate, but stable impairment due to deficit symptoms that do not progress. 
The remaining 30% have persisting, progressive cognitive deficit symptoms that 
cause increasing impairment without return to baseline (Leff, Dayson, Gooch, 
Thornicroft, & Wills, 1996). Pearlson (2000) asserts that these patients with 
severe and persistent impairment who do not return to baseline are the patients 
who in the past were most likely to have remained in chronic state hospital 
facilities, but with the advent of deinstitutionalization, were more likely to 
become homeless or jailed.  
Mohamed, Paulsen, O’Leary, Arndt, and Andreasen, (1999) in their study 
of 73 never-treated patients concluded that the cognitive disturbance in 
schizophrenia is such a complex and diverse phenomenon that the older models 
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used to understand the problem fall short in describing it. The disruption in the 
fundamental circuitry in the brain leads to impairment in all cognitive systems and 
subsystems, including memory, attention, language, and executive functions. 
Indeed, neurocognitive deficits are a key symptom domain in schizophrenia and 
are the more significant predictors of functional outcome (Glaser, 2002). 
Although most researchers recognize the incapacitating nature of cognitive 
deficits, the debate continues to be about the relationship between the onset of 
dysfunction to the onset of illness. Schizophrenia has its cycles. Herz (1991) 
describes them as periods of remission alternating with periods of increasing 
illness. These periods of illness culminate in relapse - the reoccurrence of a 
psychotic illness. Most patients will suffer a relapse within two years of an acute 
episode. These disruptions to social and vocational lives from relapse can cause 
lasting damage. Therefore, it is important for patients and their families to 
recognize the early signs of relapse to prevent a full relapse from occurring. 
Recidivism 
It has been widely reported that there is a significant predictive 
relationship between the single variable of previous hospitalization and frequent 
rehospitalization (Goodpastor & Hare, 1991). Swett (1995) looked at consecutive 
patients (n = 189) entering an acute admissions unit and found that previous 
psychiatric readmission was a factor, but added the variable of higher acuity on 
discharge. He noted that these variables might also indicate incomplete inpatient 
treatment during an earlier stay or poor follow-up after discharge. Additionally, 
Haywood et al., (1995) reported that the readmission rates for psychiatric patients 
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are increased as a function of drugs and alcohol problems and medication 
noncompliance.  
A seven year study by Marom, Munitz, Jones, Weizman, and Hermesh 
(2005) of 93 patients with schizophrenia and 15 with schizoaffective disorder 
looked at expressed emotion (EE) as another predictor of long-term outcome for 
these patients. Using a Five Minute Speech Sample (FMSS), the key relatives of 
the patients were categorized as either high or low on EE, and its two 
components, criticism (CR) and emotional overinvolvement (EOI). The EOI 
component was found to be insignificant while high CR compared to low CR was 
associated with higher rates of readmission and longer hospital stay. Moreover, 
they concluded that EE could be of value as a predictor of the clinical course of 
schizophrenia and should be pursued for long-term prevention interventions.   
Although contrary to the study that Appleby et al. performed in 1993, 
Swett (1995) did not find a shorter length of stay to be a significant predictor for 
more frequent or early readmission. However, Goodpastor and Hare (1991) in 
their retrospective review of hospital records of 207 patients with 547 
readmissions, found that age and sex were stronger predictors of length of stay 
than even the diagnosis while noncompliance with medication (Docherty, 2003; 
Haywood et al. 1995; Love, 2005) and therapy appointment were the only 
significant predictors of rapid relapse. Similarly, the educational modules 
developed by Liberman had no significant effect on the number of readmissions, 
but did have an effect on their duration (Stenberg, Jaaskelainen, & Royks, 1998).  
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Prince (2006) looked at rehospitalization rates during the first three 
months after hospital discharge for 264 patients with schizophrenia. He found that 
services addressing symptom education, care continuity, and daily structure were 
more effective than other interventions in preventing rehospitalization. Likewise, 
Nelson, Maruish, and Azler (2000) found that in patients who kept their outpatient 
appointments, the readmission rate stayed the same over time, whereas, the 
patients who did not had significantly higher rates.  Interestingly, it was also 
noted that patients who had no outpatient appointment after discharge were two 
times more likely to be rehospitalized in the same year than the patients who kept 
at least one outpatient appointment. Relapse rates can also be effectively impacted 
by family-based intervention programs (Pollio, North, Reid, Miletic, & 
McClendon, 2006; Razali & Yahya (1995). 
Treatment Issues 
As they age, patients with schizophrenia have greater risk than the general 
population of developing other illnesses such as type 2 diabetes, cardiovascular 
abnormalities, hypertension, or other disorders (Davidson, 2002; Goldman, 1999; 
Vieweg et al. 2002), including dementia, although there is no increased risk for 
Alzheimer’s disease (Citrome, 1998). In addition, many of the newer atypical 
antipsychotic medications may also elevate blood sugar levels and cause 
excessive weight gain (Vieweg et al. 2002). Other unhealthy behaviors that put 
them at risk include abuse of nicotine, alcohol, and other substances. It is believed 
that patients with schizophrenia are self-medicating with these substances. In fact, 
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research done by Conley (2000) has suggested that there is a link to improved 
mood and reduction of psychotic symptoms with nicotine use.  
Goldman (1999) believes that mental illness complicates things since 
these patients may not volunteer medical complaints or may have difficulty in 
communicating their problem to the physician. Indeed, in the retrospective study 
of some 370 psychiatric admissions with the diagnosis of schizophrenia, Brown, 
Barraclough, and Inskip (2000) found that of the 79 patients, who had died, three 
were due to the failure of either the patient or the physician to recognize a disease. 
In some cases, the effects of psychotrophic drugs or substance abuse may also 
complicate the patient’s medical illness. Then, in other cases, the medical 
conditions may be overlooked because patients with schizophrenia have a high 
pain threshold (Dixon, 2003; Dworkin, 1994; Goldman, 1999) and simply don’t 
complain.   
Added to the other risks associated with obtaining medical care for the 
patient with schizophrenia is the long-standing separation of treatment for medical 
and mental illnesses. Daumit et al. (2002) found in their study of preventative care 
for patients with severe mental illness that psychiatrists provided services for 
medical illnesses only 11 percent of the time. The physicians cited lack of training 
as a major barrier to their delivery of these services. However, it has been shown 
that when referrals to primary care are made, they are often given low priority by 
the patient because of more pressing concerns or lack of   understanding of the 
benefits.  
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In a study by Brown et al. (2000), it was found that poor compliance with 
treatment definitely caused at least one death and may have been responsible for 
some of the other 58 deaths from diabetes, epilepsy, stroke, and respiratory 
diseases. Poor compliance with treatment is also associated with blame for the 
patient and they may be involuntarily discharged from treatment (Montoya, 
2006). At any rate, victims of both their illness and a fragmented healthcare 
system, patients with schizophrenia are less likely than those in the general 
population to receive adequate healthcare (Crews, Batal, Elasy, Casper, & 
Mehler, 1998; Dixon, 2003; Dixon et al. 2001; Goldman, 1999). 
Comorbidity 
 Kosten and Douglas (1997) note that up to 50 percent of individuals with 
schizophrenia have either alcohol or illicit drug dependence and about 70 percent 
or more are nicotine dependent. In a recent report by the Substance Abuse and 
Mental Health Services Administration, drug and alcohol use were found to be the 
major reason for more than 1 million emergency department visits annually 
(Ziedonis & Williams, 2002). Additionally, Swartz et al. (1998) found that 
noncompliance and substance abuse may be mutually reinforcing problems in that 
substance impairment may impede medication adherence while noncompliance, 
in turn may lead to self-medicating with alcohol or illicit drugs.  
A self-medication hypothesis has suggested that the use of these drugs 
may acutely ameliorate some negative and positive symptoms of schizophrenia, 
but the chronic effect of these abused drugs is detrimental to the psychological 
wellbeing of  these patients. These detrimental effects may either be the 
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consequence of not taking prescribed antipsychotic medication or result in 
actually precipitating psychotic symptoms (Kosten & Douglas, 1997). Haywood 
et al. (1995) found that rehospitalization rates increased also as a function of 
alcohol and drug problems and medication compliance. Clearly, substance abuse 
among psychiatric patients, especially those with schizophrenia, worsens 
prognosis, and increases both the likelihood of institutionalization and risk of 
dependence on the chemical substance (Ziedonis & Williams, 2002).   
 Most patients with schizophrenia will express symptoms of depression at 
some point during their illness. The reason may be related to many different 
factors in any given domain - physical, psychological, social, or spiritual. 
Nasrallah and Tandon, (2002) report that depressive symptoms are present in up 
to 60 percent of patients with schizophrenia. The depression complicates the 
clinical picture of schizophrenia by interplaying with all other core symptom 
domains that include positive symptoms, negative symptoms, and cognition. It 
affects compliance, social and vocational functioning, reintegration, and risk for 
suicide in this already vulnerable population (Petty, 2001).   
Depressive symptoms affect the overall quality of the patient’s life and 
may contribute to the high lifetime rate of completed suicide and suicide attempts. 
In fact, the major warning signs for suicidality in this population include 
depression  (Siris, 2001), feeling that their illness is beyond their control, and a 
sense of hopelessness (Meltzer, Davidson, Glassman, & Vieweg, 2003; Rossau & 
Mortensen, 1997). Indeed, Gupta, Black, Arndt, Hubbard, and Andreasen (1998) 
from their comparative study of male patients (n = 336) with schizophrenia who 
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had a lifetime history of a suicide attempt found that depressive episodes and an 
earlier age of onset were more predictive of suicidal behavior than drug or alcohol 
abuse.  
Suicide 
Aggression towards the self is one of the most serious of schizophrenia 
behaviors (Glazer, 2002) and is reportedly the leading cause of premature death 
among these patients. As the eighth leading cause of death among all age groups, 
Noffinger and Knoll (2003) calculated that at least 30,000 persons in the United 
States commit suicide each year. It is estimated that 10% of people with the 
diagnosis of schizophrenia will have a completed suicide (Gupta et al. 1998; Roy, 
1982); but attempts are made at two to five times that rate (Miller, 2003; Rossau 
& Mortensen, 1997;). In fact, Simon and Gutheil (2002) note that males of all 
ages, including those with schizophrenia, have a higher incidence of suicide than 
females. Destructive acts against the self include suicide and parasuicide or self-
injurious behavior. However, Singer (1986) believes that attempted suicide and 
parasuicide are more often attempts to control others rather than true self-
destructive intent; but notes that both must be taken seriously since even the 
manipulating patient may accidentally succeed. 
In addition to the presence of depression and psychosis, poor functioning 
is one of the greatest risk factors for suicide in schizophrenia. Some other key 
factors include inadequate medication, noncompliance, treatment resistance, 
communicated intent, substance abuse (Conley, 2000), and intimate partner 
violence (Heru, Stuart, Rainey, Eyre, & Recupero, 2006). Recent original research 
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conducted in Canada (Kontaxakis et al. 2004) with a small sample of patients with 
schizophrenia (n = 93), added several social factors such as young age, male sex, 
single, unemployed, previous suicide, and multiple relapses to the list of risks. 
Moreover, Brown et al. (2000) and  Noffsinger and Knoll (2003), contrary to the 
findings by Gupta et al. (1998), believe that when serious drug or alcohol abuse is 
factored in, the risk is increased and the true death rate among those with 
schizophrenia is even higher than their research suggests.  
Suicide risk factors may vary in different treatment phases among patients 
with schizophrenia (Heila et al. 1999). For example, young patients early in the 
course of schizophrenia are more likely to commit suicide than are older patients. 
Among inpatients, those with a negative attitude toward treatment had the highest 
proportion of suicide while recently discharged patients had the highest 
prevalence of comorbid alcoholism, paranoid subtype, recent suicidiality, and 
short last hospitalization (Heila     et al. 1999; Rossau & Mortensen, 1997). In 
their 2006, study of 110 psychiatric patients, Heru et al., found that there was also 
high prevalence of intimate partner violence (IPV) in these inpatients. Unhealthy 
family functioning and alcohol abuse in males were factors. Although the 
relationship between IPV and sucidiality is not direct, the prevalence for both 
genders is greater than 90%. Additionally, from their anecdotal report on more 
than 100 suicide cases Simon and Gutheil (2002) added that isolation on the 
inpatient unit, withdrawal and detachment from relationships, and failure to form 
a true therapeutic alliance with the psychiatrist and staff significantly increased 
the suicidal risk factor. 
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The risk for suicide was found to be higher during the first 6 months of 
discharge (Rossau & Mortensen, 1997); but with patients with schizophrenia, 
30% occurred within the first month after discharge and the next highest was 
during the first week of admission. These findings suggest that the change from 
longer, less frequent stays in the hospital to shorter, more frequent readmissions 
may have a significant negative impact on the suicide risk (Palmer, Pankratz, & 
Bostwick, 2005). Patients are particularly vulnerable during these transitional 
periods and there is need for increased preventative measures during this time 
(Palmer et al. 2005). Clearly, as Conley (2000) has noted, suicide is a frequent 
and serious outcome of schizophrenia. 
Violence and Incarceration 
Similar to the suicidal risk factors for this population, being male or 
having a history of substance abuse is also correlated with violent behavior 
(Nolan, Citrome, & Volavka, 1999; Oster et al. 2001). However, men are only 
slightly more likely than women to use physical aggression in violent incidents 
(Oster et al. 2001). In fact, when Oster et al. (2001) reviewed 99 violent or 
potentially violent patients, they found that psychotic disorder, history of previous 
violence, and a low GAF score (< 26) were also predictors. Indeed, they believe 
that these factors were more clinically important predictors than even substance 
abuse. 
In 1998, Swartz et al. enrolled 331 involuntarily admitted inpatients in a 
longitudinal with study to look at violence among persons with severe mental 
illness. Those selected as subjects predominately had diagnoses of schizophrenia, 
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schizoaffective disorder, or other psychotic disorders. The racial distribution was 
about two-thirds African American and one-third Caucasian which is quite 
representative of the severely mentally ill population in urban public hospitals. 
Although they found that African Americans were no more likely than Caucasians 
to commit violent acts, the study did confirm that substance abuse, medication 
noncompliance, and low insight into illness operate together to increase violence 
risk.  
Although violent behavior occurs infrequently among patients with 
schizophrenia, Nolan et al. (1999) believes that most patients with schizophrenia 
are not violent. They note that violent events are related to the severity of the 
patient’s psychosis or psychotic symptoms, particularly auditory command 
hallucinations and are a principal reason for both psychiatric hospitalization 
(Nolan et al. 1999) and incarceration (Lamb & Weinberger, 1998). There is 
evidence that there is increased aggressive behavior associated with schizophrenia 
relative to the general population, but consumer and advocacy groups feel that 
portraying the person with schizophrenia as dangerous is unnecessarily 
stigmatizing. Thus, experts in the field resolve the conflicting perspectives by 
pointing out that it is the untreated as opposed to the properly treated patient with 
schizophrenia who is at greater risk for violence (Pomerantz, 2003). This also 
relieves the patient from responsibility for their behavior. 
Aggression or destructive behavior may be directed to objects or people 
(Singer, 1986) and may further erode supportive social and therapeutic 
relationships (Swartz et al. 1998). Unfortunately, society has limited tolerance for 
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deviant behavior and the violent patient often enters the criminal justice system. 
The term criminalization has been applied to the arrest and prosecution of persons 
with mental disorders rather than placing them in the mental health system (Lamb 
& Weinberger, 1998). Miller (2003) offers several factors that led the movement 
of patients from hospital to jail. Foremost was deinstitutionalization which was an 
objective series of events that led to a massive shift in the locus of care for 
chronic mental patients (Bachrach, 1992).   
The series of events began with the introduction of more effective drugs to 
treat serious mental illnesses during the mid-1950s, which started the bed 
reductions in state facilities. In 1965, Medicaid came on the scene and states 
found that they were able to shift their financial burden to the federal government. 
However, the federal government added a provision to the Medicaid law that 
excluded payment of services for patients in state psychiatric hospitals or other 
such “institutions for mental diseases” which came to be called the IMD 
exclusion. Finally, this exclusion not only led to the obligatory reduction of 
psychiatric beds in state hospitals; but to the fact that, in general, there were 
insufficient resources available to the severely and persistently mentally ill (Hurd, 
2001).   
The advent of deinstitutionalization probably did set the table for mentally 
ill persons to move to the criminal justice system. In about 40 years, the United 
States reduced the number of occupied state hospital beds from 339 per 100,000 
population to 29 per 100,000 on any given day (Lamb & Weinberger, 1998). 
Appleby et al. (1993) had clearly demonstrated in their 18-month study of 1,500 
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patients with schizophrenia that there was a linear relationship between length of 
stay and relapse rates. So when hospital beds became less available, these patients 
were most likely among those caught in the “revolving door” of frequent hospital 
readmission for psychiatric care. However, now they were caught in the 
“revolving cell door” bouncing between state hospitals and jails (Lamb & 
Weinberger, 1998).  
A review of the literature from clinical studies from 1970 through 1998, 
that suggested that 10-15% of persons in state prisons have severe mental illness. 
This also supports the contention that the mentally ill are being increasingly 
processed through the criminal justice system (Lamb & Weinberger). Pomerantz 
(2003) reports that the prison census conducted by the U. S. Department of Justice 
in 2000, determined that nearly 13% of inmates in state-run institutions received 
some form of mental health care from a trained professional on a regular basis. 
However, at mid-year 2005, a special report of the Bureau of Justice found that 
the numbers of jail inmates reporting mental health problems have swelled to 56% 
of State prisoners, 45% of Federal prisoners, and 64% of jail inmates (U.S. 
Department of Justice, 2006). 
One can better appreciate the impact of these percentages when the actual 
numbers are given. A study by Miller (2003) in 1995, noted that there were 
approximately 70,000 persons with severe mental illness in public psychiatric 
hospitals and by 1999, the numbers had swelled to about 283,000 persons with 
severe mental illness being incarcerated in state and federal jails and prisons. 
These 283,000 persons account for approximately 16% of the prison and jail 
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inmate population. According to Miller (2003) jails and prisons have become the 
defacto psychiatric institutions in the United States. Lamb and Weinberger ) 
believe that this is because law enforcement and courts do not want to give the 
perception that they make a difference between offenders. They note that even 
police officers see the criminal justice system as a more systematic way to deal 
with psychiatric cases. Moreover, some in our society view mental illness as 
volitional and being used to deliberately avoid punishment. In general, because of 
fear of the mentally ill person who commits a criminal offense, the public tends to 
believe that any sentence other than prison is too lenient for serious offenders 
(Lamb & Weinberger). 
The fact is that most persons with mental illness who are involved in the 
criminal justice system usually have short stays in local jails rather than long stays 
in prison (Miller, 2003). Many would have never have landed behind bars in the 
first place if there were adequate community care. On release from either 
institutional system, however, very little attention has been given to after care 
planning and treatment, case management services, or social support. It is 
estimated that of those on probation, about 550,000 are believed to have severe 
mental illness (Miller). Moreover, Miller relates that of the estimated 600,000 
homeless persons in the United States, 240,000 are believed to have chronic 
mental illness.   
Homelessness 
Experts cannot agree on the definition of homelessness much less the 
actual number of mentally ill persons who are homeless. For example, in 1983, an 
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estimate was given by the Alcohol, Drug Abuse, and Health Administration of 
there being about 2 million homeless persons in the United States. However, the 
following year, the U.S. Department of Housing and Urban Development rejected 
that estimate and released their numbers as being only 250,000 to 350,000 
homeless people in the country (Bachrach, 1992).   
According to Bachrach (1992), critics believed these numbers to be 
politically motivated and pointed out that if, conveniently, the homeless people do 
not exist in large numbers, one need not think about how to serve them. She 
cautiously reports that current estimates from communities throughout the United 
States generally run from about one-third to one-half of the total homeless 
population. Therefore, she notes that any percentages used must consider how this 
population is defined, which portion of the population is being viewed, and in 
what part of the country (Bachrach). 
Draine, Salzer, Culhane, and Hadley (2002) critically analyzed the 
approach used in current psychiatric service literature to infer links between 
mental illness and social problems. They argued that persons with mental illness 
experience social problems more frequently simply because they live in a world in 
which these problems are endemic, not just because they are mentally ill. 
Homelessness is more than a mental health problem.  It affects a broader segment 
of the poor in general and is not unique to people with a mental illness. They note 
that factors that relate to poverty are complex and include lack of education, 
problems with employment, substance abuse, and a low likelihood of pro-social 
attachments. Thus, they want to focus research and policy to better address this 
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complexity to more effectively provide interventions for persons with serious 
mental illness. 
All states struggle with the problem of inadequate resources for the 
deinstitutionalized mentally ill. However, a surprising statistic is that the homeless 
mentally ill population is not predominantly those from long-term stay; but 
instead from the mentally ill who have never become properly engaged with 
psychiatric services (Leff et al. 1996). In their study on recidivism in the 
psychiatric emergency room, Dhossche and Ghani (1998) found that the patients 
were often young persons with schizophrenia and substance abuse issues. Most 
often unemployment and homelessness were strong correlates of multiple visits.  
In 1997, Morse et al. reported that almost 14 million Americans have been 
homeless at some point during their lifetime and nearly a third of this population 
suffers from severe mental illness. They also note that in most cases the mental 
illness preceded becoming homeless. They followed outpatient mentally ill 
persons (n = 135) who were homeless or at risk of homelessness for 18 months to 
determine the most effective type of case management services to obtain housing, 
stabilize symptoms, and elicit satisfaction with their treatment program. They 
found that assertive community treatment was superior to the less costly type of 
brokered case management (Morse et al.).  
Community treatment services are provided directly with a 10 client to 
one staff ratio while brokered case manager services are arranged through a 
variety of providers. Since there can be a much larger client-to-staff ratio that is 
on the average of one staff to 85 clients these services are less costly. 
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Additionally, broker case manager is only required to assess the needs of the 
client and can then vary the mix and frequency of services for each client on an 
individual basis. In many cases, the clients fell through the cracks while awaiting 
services that either forgot appointments, became lost in the system, were denied 
treatment, or finally just refused services (Morse et al) 
The homeless have a mortality rate four times that of the baseline 
population (Crews et al. 1998). These patient often get labeled as noncompliant 
due to recidivism, but may actually be victims of poorly designed or mismatched 
services. Indeed, Cohen (1993) finds that labeling patients this way can lead to a 
stigmatizing “blame the victim mentality” among professionals. Because of their 
inherent paranoia, mentally ill patients are more likely to return for follow up and 
adhere to treatment plans if they trust the health care staff (Crews et al. 1998). 
Thus, for more successful outcomes, community resources must be well planned 
and available to the patient (Dhossche & Ghani, 1998; Leff et al. 1996). 
Noncompliance 
Noncompliance or poor compliance with treatment recommendations 
plagues every aspect of medical practice. Platt et al. (1994) found that generally 
only one-third of patients actually follow medical and lifestyle recommendations 
completely and correctly, another third attempt to follow instructions, but do so 
incorrectly, and the remainder completely fail to follow them. The reasons are 
varied and complex, but not confined to patients with a mental illness. In their 
1996 study, Johnstone and Sandler determined that limited response to treatment 
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could occur even when drugs are being taken correctly and adequate plasma 
concentrations are achieved. 
Clearly, patient adherence to a medication regimen is influenced by many 
competing factors. Some predictors of nonadherence include the decrease in 
active symptoms, side effects of medications, the patient’s health belief system 
(Perkins, 1999), poor insight, stigma of mental illness, and poor therapeutic 
alliance (Lacro et al. 2002). Others are environmental issues such as lack of 
supervision, continuity of care, and even homelessness  (Dixon et al. 1997). 
Similarly, in their study of noncompliance in asthma patients, Schaffer and Lopes 
(2003) found that psychosocial factors such as rejection of the diagnosis, coping 
strategies and cultural factors may also lead to lower levels of adherence.   
Noncompliance with antipsychotic medications is a common problem in 
discharged patients. It is estimated that the prevalence of noncompliance is as 
much as 50% after one year and 75% at two years. In 1997, Dixon et al. reported 
the annual economic impact of schizophrenia noncompliance rehospitalization 
costs at $800 million; however, by 2003, the estimated costs directly related to the 
rehospitalization costs of these patients had risen to between $33 to $65 billion 
(Cooper et al. 2003; Marder, 2002). Indeed, compliance is a complex issue and 
varies over time.  
In 1992, the Agency for Health Care Policy and Research and the National 
Institute of Mental Health funded the Schizophrenia Patient Outcomes Research 
Team (PORT) to develop and make recommendations for treatment of 
schizophrenia based on research findings. A comprehensive synthesis of the best 
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well-controlled scientific studies and treatments were reviewed and thirty 
treatment recommendations along with the supporting evidence emerged three 
years later. The PORT research project targeted many areas including 
antipsychotic agents, electroconvulsive therapy, psychological and family 
interventions, and aftercare follow-up services. The idea was to identify strengths 
and limitations in the current knowledge base and to begin moving toward an 
“evidence-based” practice for schizophrenia (Lehman, Steinwachs, & the Co-
investigators of the PORT Project, 1998).   
In 1998, using questionnaires, interviews, and medical record review the 
team administered the PORT Client Survey with a random sample of 719 persons 
with the diagnosis of schizophrenia who were under usual care in two states – one 
in the South and the other in the Midwest. The team then measured the rate of 
conformance with the recommendations. They noted that for most 
recommendations, less than half the patients were receiving treatment that met the 
recommendation criteria; but treatment of patients in rural areas was closer to the 
recommendations than those in urban areas. Their conclusion was that there are 
still broad variations in patterns of care for persons with schizophrenia, even 
under usual treatment conditions in relationship to scientifically based treatment 
standards that must be addressed (Lehman et al. 1998). 
Some have suggested that we would be better served to view compliance 
as a continuum since it is associated with relapse and rehospitalization. However, 
Conley  (2000) believes that we should view it as an indication that prescribed 
treatment is not adequately assisting the patient to achieve his/her goals. 
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Compliance is best dealt with through repetition. We must provide education to 
the patient especially on how to participate in monitoring their own medications 
and include memory enhancements by incorporation of these into their daily 
routine. 
In fact, one of the current challenges in the management of schizophrenia 
is the treatment of patients who do not respond well to standard therapy. The 
newer atypical antipsychotics may be helpful to a number of these treatment 
resistant patients, but they have not been the hoped for panacea. A large majority 
of patients with schizophrenia who remain institutionalized are made up of the 
patients who do not respond to typical antipsychotic agents and many more such 
patients can be expected to have only a partial response (Citrome, 2004). 
Antipsychotic medications that were developed around the 1950s made it 
possible for most patients with schizophrenia to be treated in the community 
rather than in custodial institutions. These conventional medications or first 
generation antipsychotic medications were made available in oral liquid and 
tablets, and both short-term and long-term injectable form. Although inexpensive 
and available, these drugs often produce significant side effects that are 
unacceptable to the patient. They include disabling extrapyramidal symptoms 
(EPS) that produce a zombie-like appearance, hypotension, anticholinergic 
effects, and cognitive impairment. Moreover, Karki, Bellnier, Patil, and Oretega 
(2001) found that in the patient with schizophrenia, the effects of conventional 
antipsychotic medications have shown poor outcomes and high relapse rates even 
in stabilized patients.   
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In the 1990s, researchers sought to develop compounds with the 
equivalent antipsychotic activity but without the terrible side effects such as EPS 
(Nasrallah & Tandon, 2002). The addition of these newer alternative medications 
offered better outcomes in the area of improved cognition and compliance when 
compared to the traditional drugs. However, Pomerance (2004) reports that 
adherence with the oral atypicals is no better than any other medication. Only the 
injectable forms can improve patient adherence. Since it assures both reliability 
and consistency in dosing, Marder et al. (2002) prefer the long-acting injectable 
antipsychotics, also called depot injection, the route of administration for the 
long-term treatment of schizophrenia. Patients receiving the injections every 2-4 
weeks, on the other hand, may not agree with the researcher’ perspective. 
Although atypical medications may be 100-200 times more expensive that 
the generic version of one of the older typical antipsychotic medications, Karki et 
al. (2001) believe that they are really more cost effective when one considers the 
total cost of disease management including the cost of multiple hospitalizations. 
Once thought to be last resort, the atypical agents are now generally the first 
choice and mainstay of treatment for patients with refractory schizophrenia (Pies, 
1999).   
Treating patients with drugs that have a decreased likelihood of producing 
side effects is important for number of reasons. In schizophrenia, long-term 
treatment is necessary and significant adverse effects can contribute to patient 
noncompliance with medication leading to relapse. Early and consistent treatment 
of psychotic symptoms may improve the long-term prognosis of patients 
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(Duzyurek & Wiener, 1999; Nasrallah & Tandon, 2002). Kennedy et al. (2001) 
note that atypical neuroleptics have been credited with partially ameliorating the 
neurocognitive deficits produced by the older agents. This is a vitally important 
area to consider when treating patients with schizophrenia since cognitive 
impairments correlate strongly with community functioning, including social and 
vocational measures.  
Talbott, Bachrach, and Ross (1986) conclude that no more that 25% of 
former mental hospital patients continue in regular after care and despite 
recommendations to the contrary, fewer than one half take medication regularly. 
In their review, it was suggested that the most important elements in the treatment 
of the chronic mentally ill are continuance on medication and participation in 
some sort of aftercare program. Dysfunction in this area may be implicated in 
those patients who continue to struggle with their reintegration back into the 
community despite an improvement in positive and negative symptoms. Since 
there is evidence that with each relapse schizophrenia becomes increasingly 
resistant to treatment (Herz, 1999; Karki et al. 2001; Pies, 1999), it is imperative 
that a variety of strategies be employed to improve patient compliance.   
Multiple areas that have potential for positive intervention have been 
identified.  For example, in 2000, Glazer did a 4 week study of noncompliant 
patients (n = 52) in which he found that they perceived themselves as having less 
family support and a poorer therapeutic alliance with the treatment team. 
Successful treatment is dependent on the patient being able to deal with fear, 
control issues, and relationships – both with family and therapeutic care providers 
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(Conley, 2000). Likewise, Green (1988) found that the points best able to 
interrupt the revolving door cycle are when outpatient noncompliance is identified 
and rehospitalization is recognized. At both junctures, he believed that the 
community mental health system might intervene to ensure compliance with 
further outpatient treatment so that further decompensation might be avoided. 
Given the current climate of healthcare, care in the community involves an 
increasing number of psychotic patients whose compliance with their medication 
regimens cannot be closely supervised or monitored. As previously noted, 
noncompliance is a problem with all patients, but is particularly acute with those 
receiving antipsychotic medication, partly due to the adverse effects of these 
drugs and partly due to the perception of some patients that medication is either 
excessive or altogether unnecessary (Pinto, 1997).   
Failure to comply with medication leads to significant risk of relapse and 
rehospitalization not to mention the risk that deteriorating behavior can lead the 
patient into acts of self-harm, serious social problems, or even criminal crises. In 
his study of the attitudes and perceptions by patients (n = 182) living in the 
community about their medication, Pinto (1997) determined that the majority of 
the patients surveyed wanted more information from their doctors and nurses. 
Possibly this flow of information from health care providers is limited due to the 
assumption that the impaired cognitive ability of chronic mentally ill patients 
limits their understanding of the effects of their medications and illness. However, 
it has been demonstrated that patient education may improve compliance.   
Psychosocial Education 
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Education has been shown to increase compliance, improve self-reliance 
after hospitalization, and reduce rates of readmission for mentally ill patients 
(Basskin, 1998; Goldman & Quinn, 1988; Penn and Mueser, 1996; Platt et al. 
1994; Ruscher, de Wit, & Maazmanian, 1997). Shaffer and Lopes (2003) agree 
that educating patients is a cost-effective measure that improves outcomes and 
motivate high-risk patients to adhere to the treatment plan. Over two decades of 
skills training including chemotherapy has been regarded as a major psychosocial 
intervention strategy (Hogarty et al. (1991). 
Obviously for any medication to be effective, it must be taken.  Perkins 
(1999) points out that there are many factors that impact nonadherence to the 
medication regimen. To address the issue, therapeutic interventions must address 
the patient’s  specific concerns and beliefs. She also notes that a growing body of 
empirical evidence suggests that clinicians can use psychoeducational and 
cognitive behaviorally oriented psychotherapeutic strategies to improve 
medication adherence.  
Psychoeducation is defined by Goldman (1988) as education or training of 
a person with a psychiatric disorder in subject areas that serve the goals of 
treatment and rehabilitation. It is provided by the patient’s treatment team along 
with antipsychotic medication and other rehabilitation strategies. People with 
schizophrenia need help with virtually every aspect of their lives and the goal is to 
strike a balance between their protection and their independence. Since about a 
third of patients with schizophrenia live with their families, they also need 
education, support, and reassurance to cope with their loved ones illness. 
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Moreover, there is evidence that providing education for both the family and the 
patient lowers relapse rates (Leff, 1989), improves the family atmosphere  
(Harvard Mental Health Letter, 2001) and reduces family burden (Penn & 
Mueser, 1996; Pollio et al. 2006). 
Skills training that include social and independent living skills have 
become a psychosocial adjunct to antipsychotic drug therapy and psychiatric 
rehabilitation. In an 18 month study comparing 41 male veterans who met the 
criteria for schizophrenia, Eckman et al. (1992) randomly assigned half to either a 
structured skills training group or a supportive psychotherapy group. They found 
that the patients who received skills training using educational modules made 
significant gains in each of the areas taught, while those participating in group 
therapy did not. These educational modules have been shown to have positive 
effects on the acquisition of new knowledge and skills. Moreover, the researchers 
noted that the skills learned during training were retained without significant 
erosion over a one year follow-up period. 
Further support for skills training came from the extensive review by of 
multiple studies on nonadherence by Fenton, Blyler, and Heinssen (1997) from 
the period of 1960 to mid-1990. They found that educational interventions simply 
aimed at providing factual information about schizophrenia and its treatment have 
been ineffective at increasing compliance. However, when skills training was 
provided in areas related to medication, it was more effective and the participants 
in the educational group intervention made fewer knowledge errors at the one 
month follow-up than those who were in the control group. 
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In 1996, Dilk and Bond conducted a quantitative meta-analysis covering 
the decades of 1980 and 1990, to evaluate the research on skills training for 
individuals with severe mental illness. They reviewed 68 studies and found that 
although the methodology was generally very good, most of the studies were done 
in psychiatric hospital settings and involved mostly male or all-male samples. 
They concluded that the predominant approach in the skills training literature is 
social skills training; but this approach can’t be extrapolated to everyday 
functioning. They also believe that more research is needed using more diverse 
populations and diagnostic groups other than schizophrenia. Nevertheless, they 
were in agreement with most other reviews that behavioral skills training for 
persons with severe mental illness is effective for teaching inpatients interpersonal 
and assertiveness skills.   
Recent emphasis on community care has produced various models for 
family intervention. Family based programs use the resources of the family unit to 
increase compliance and decrease the impact of stressors that could trigger 
relapse. Families become an invaluable component in the long term care of these 
individuals.  Although the effort to maximize the functioning of the ill family 
member increases the burden that these families must carry (Doornbos, 2001), 
psychoeducational family programs have been found to be effective. Razali and 
Yahya (1995) conducted a study of 225 patients with the diagnosis of 
schizophrenia who were admitted to a psychiatric unit for relapse and found that 
compliance was significantly better when medication was supervised at home. 
They concluded that psychoeducational family programs effectively reduced 
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relapse and although medication compliance was not their sole mechanism of 
action, it was an important side effect.   
Several studies have found that patients who are knowedgable about their 
disease and treatment are more motivated to adhere to the treatment plan 
(Birchwood et al. 1993; Drake et al. 1994; Platt et al. 1994; Shaffer & Lopes, 
2003). In their 2004, retrospective study of 4,325 California outpatients with 
schizophrenia being treated with antipsychotic medication, Weiden et al. found 
that lower medication compliance was the most statistically significant risk factor 
associated with a higher risk of hospitalization. Given this strong association, 
Haywood et al. (1995) emphasized the importance of patient education as a cost-
effective intervention to break the “revolving door” phenomenon among the 
mentally ill.  
Summary 
 Schizophrenia is a serious mental health problem that affects 
roughly 1% of the population. It has devastating effects on the individual, their 
families, and our society.  The very nature of the disease is recidivism and 
readmission even with medication adherence; however, because of their flawed 
thinking, many patients relapse due to noncompliance with medication. 
Healthcare professionals must avoid labeling the seriously mentally ill patient 
who does relapse as noncompliant as this stigmatizes them and may compromise 
their future care. Many studies have demonstrated that adherence is learned 
behavior and the educational strategies that target symptoms, service continuity, 
and daily structure are most effective in improving medication compliance and 
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reducing rehospitalization. Poorly designed, mismatched services, or no 
outpatient services on discharge from mental hospitals may lead to the revolving 
door cycle of medication/treatment noncompliance and rehospitalization. Other 
issues facing the mentally ill patient are unemployment, stigma, substance abuse, 
suicidal thoughts, physical illness, and homelessness. Additionally, a small 
number of patients with schizophrenia demonstrate violent or bizarre behaviors in 
public that may gain them entry into the criminal justice system rather than a 
hospital.  
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Chapter 3         
Methodology 
Introduction to the Study 
 The purpose of the study was to determine the effect of participation in 
patient psychosocial education activities while hospitalized had on admission 
rates among patients with schizophrenia. Of the research on the effects of patient 
education, few specifically target the patient with schizophrenia for study. 
Chapter 3 provides a description of the design, methods, procedures, and data 
scollection and analysis used in the study. 
Design 
The study was a retrospective design using data from a medium sized state 
mental hospital. Data were accessed over a nine year period (July 1, 1997 to June 
30, 2006). The study compared data from both sample and control groups.       
Selection of Subjects 
Sample selection for this study was convenience. The sample included all 
patients with the diagnosis of schizophrenia admitted for the first time during the 
12 month period from July 1, 1997, to June 30, 1998, to the Acute Care Program 
of a 172 bed state psychiatric facility. These patients were coded as to whether 
they received the intervention or not. Admission data for the period of July 1, 
1998, to June 30, 2006, were then reviewed to determine the readmission rate, 
intervals between admissions, and length of stay for the original sample. 
Protection of Human Subjects 
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 Data were obtained from complied statistics from the departments of 
Medical Records, Patient Education, and Standards and Compliance in the 
facility. These data were coded to assure patient anonymity. They included the 
following demographic information: age, gender, diagnosis, and global ability to 
function (GAF). Otherwise, these data have no identifying information about the 
patients.   
On admission to the facility, the patient signs for release of information to 
the hospital. Data are collected by the hospital for quality improvement activities 
using patient numbers. When this information is aggregated into statistical form, 
there are no specific patient identifiers. Since these data are used for risk 
management and quality improvement activities, they may become public record. 
This study was a review of retrospective data and no new data were gathered. 
Only variations within and between the groups identified are statistically reported. 
Therefore, there is no risk to the subjects and their anonymity has been assured.   
Procedures 
Permission was obtained from the Research Committee of the psychiatric 
facility to access the statistics for the study (Appendix A). Form A was submitted 
to the Human Subjects Review Board of The University of Tennessee for 
approval to conduct the study (Appendix B). However, due to the retrospective 
nature of the study, the only approval required was from the Department of 
Education Administration and Policy Studies.  
The list of all patients who were admitted during the study period of July 
1, 1997, to June 30, 1998, was obtained from the Medical Records Department of 
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the study hospital. During this period, there were 1,526 admissions. The patients 
with the target diagnosis of schizophrenia were se1ected from these admissions  
(n = 466). There were four patients under the age of 18 years who were eliminated 
from the study group since they were in another building and would not 
participate in educational groups. The study included only adult patients  
(n = 462). 
All patients met with their multidisciplinary team that included a 
psychiatrist, a Registered Nurse and social worker. During this meeting, treatment 
goals were formulated with the patient including assignment to various group 
activities and formal education classes (e.g., symptom management, medication 
management, leisure skills, anger and stress management, and others) as part of 
their inpatient treatment. Although participation in the educational classes is 
expected since it is part of treatment, patients have the right to refuse to 
participate.  It was from these assigned educational activities that the study groups 
were selected. One group were those who were assigned and participated in the 
psychosocial education classes while the other group were those who were 
assigned, but did not participate in the educational classes.  
Intervention 
Antipsychotic medication has enabled many patients with symptoms of 
psychosis to live in the community. However, medication alone has been 
ineffective in helping patients acquire the coping skills they require for life in the 
community. The social skills training model designed by the rehabilitation 
researchers at the UCLA Clinical Research Center for Schizophrenia and 
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Psychiatric Rehabilitation offered an organized approach to the deal with the 
deficits presented by patients living with chronic mental illness. The model has 
four major components – social schemata, social skills, coping efforts, and social 
competence (Liberman et al.1986). The idea is to assist the patient who has 
deficits in social skills to learn, evaluate, and practice appropriate responses to 
social situations they may encounter outside the hospital setting. For the often 
regressed, distractible, thought-disordered patient with schizophrenia sessions 
must be very structured, goal directed, but time limited. Thus, the skills modules 
were implemented to provide these learning activities at the study hospital. 
 In the mid-1990s, in addition to the usual treatment provided patients who 
were admitted to the medium sized state hospital in the study, they were offered 
the opportunity to participate in structured psychosocial education classes. The 
social skills training modules developed by Liberman et al. (1986) at the UCLA 
Clinical Research Center for Schizophrenia and Psychiatric Rehabilitation were 
purchased for use in the classes. Specifically, the selected groups for this facility 
included symptom management, medication management, anger and stress 
management, and leisure skills. Staff from the disciplines of Nursing and Activity 
Therapy received training on managing small groups, using refocusing skills, and 
the specific modules to be used. 
The skills areas (content) and the learning activities (techniques) from the 
modules were taught to the group of six to eight patients and were held 20 
minutes four times a week. The learning activities for each of the skills areas 
included identifying goals with the group, videotaped scenes for 
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discussion/question and answer, role play with positive feedback, problem solving 
using real-life situations that the patient might encounter in healthcare, and 
homework for practice of skill being taught. Finally, a checklist that evaluated 
each session (Appendix D) was completed and placed on the patient’s chart by the 
instructor so that the treating physician and treatment team who had assigned the 
patient to the educational activity could also monitor the patient’s progress.  
Interpretation of the Data 
The data for the study were gathered retrospectively from aggregated 
statistics compiled by the facility for Quality Improvement activities. Individual 
patient identity and tracking was not the focus of the facility’s purpose for the 
data. So, patients who had multiple readmissions, as most of these did, were 
repeatedly counted across the study years which confounded the data 
interpretation. In fact, many remained in the hospital for extended periods often 
crossing several years. Thus, data analysis using inferential statistical measures 
were not only inappropriate, but also impossible with these data.   
Descriptive statistics were computed on all variables including age, 
gender, and GAF scores and included measures of central tendency and 
variability. Descriptive statistics were also used to describe the differences 
between the two groups, those who received the educational intervention and 
those who elected not to participate in the educational intervention on the 
recidivism rate, length of stay and interval between admissions.  
There are three research questions guiding this study: 
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1. Do patients with schizophrenia who receive psychosocial education 
have lower relapse rates (recidivism) than those who do not receive 
psychosocial education? Question 1 was answered with descriptive 
statistics. 
2. Is there a difference between the length of stay for readmitted  patients  
with schizophrenia who have participated in the psychosocial 
education and     
those who have not? Question 2 was answered with descriptive 
statistics. 
3. Is there a difference in the length of intervals between admissions for 
the group who had psychosocial education and the group who did not? 
Question 3 was answered with descriptive statistics. 
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Chapter 4 
Findings of the Study 
Introduction to the Study 
The purpose of the study was to determine the effect that participation in 
patient psychosocial education activities while hospitalized has on readmission 
rates among patients with chronic schizophrenia.  The research questions for the 
study were: 
1. Do patients with chronic schizophrenia who receive psychosocial 
education have lower relapse rates (recidivism) than those who do not 
receive psychosocial education? 
2.  Is there a difference between the length of stay for readmitted patients 
with chronic schizophrenia who have participated in the psychosocial 
education and those who have not? 
3. Is there a difference in the length of intervals between admissions for 
the group who had psychosocial education and the group who did not? 
The retrospective data were obtained from compiled statistics over a 12-
month period from the Medical Records Department and the Department of 
Standards and Compliance from all adult admissions to the Acute Care Program 
of a medium sized state psychiatric hospital. Findings and results of the study are 
reported and discussed in this chapter using the research questions to guide the 
study. The data report begins with identification of the sample and demographic 
information.    
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Sample Identification 
Sample selection for this study was convenience. The sample of 466 
patients with the target diagnosis of schizophrenia for the study was selected from 
1,526 admissions to the Acute Care Program of a 172 bed state psychiatric facility 
during the study period from July 1, 1997 to June 30, 1998. However, four 
patients under the age of 18 years who were housed in another building were 
eliminated from the sample, which left the sample at 462 adult patients.    
The sample included adult patients with the diagnosis of schizophrenia 
who were admitted during the twelve month period from July 1, 1997, to June 30, 
1998. On admission, all patients are assigned to patient education groups 
following their first treatment team meeting. Although participation in the 
educational classes is expected as part of treatment, patients have the right to 
refuse to participate. Thus, two intervention groups were determined from these 
patients. One group was those who were assigned and participated in the 
psychosocial education classes. The other group was those who were assigned, 
but elected not to participate in the educational classes.  
The 462 participants included 279 males (60%) and 183 females (40%).  
Of these, there were 243 (53%) white, 137 (30%) black, and 82 (18%) other. The 
higher number of males is consistent with the findings of Harrow, Grossman, 
Jobe, and Herbner (2005) in their 15 year follow-up research on recovery for 
patients with schizophrenia. They report that the diagnosis of schizophrenia is 
more typical for males of this population, but females are more likely to be given 
diagnoses of depressive or other types of psychotic disorders. 
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Comparison Between the Groups 
The following data are reported to show the similarities between the self-
selected intervention and non intervention groups. There were five types of 
schizophrenia in the sample as determined by the admitting physicians at the 
participating facility. These included paranoid, disorganized, affective, 
undifferentiated, and residual. Schizophrenia, a medical diagnosis with subtypes, 
was defined by the predominant symptomology at the time of evaluation (DSM-
IV, 2000). The frequency of the different types of schizophrenia in the sample 
were disorganized -1 (.2%), residual - 3 (.7%), affective - 111 (24%), 
undifferentiated - 113 (24%), and paranoid - 234 (51%) (Table 1). 
There were 173 (38%) patients in the intervention group (those who 
participated in patient education classes) while the control group (those who were 
assigned, but did not participate in the classes) had 289 (62%) patients. None of 
the residual type participated in the educational groups and there was only one 
person from the disorganized type who participated. The intervention group 
consisted of 90 females and 83 males while the control group had 93 females and 
196 males. Chi Square analysis found that there was no significant difference 
between the groups (X
2
 = 3.11; df =1; p> 0.05) in spite of the difference in the size 
of the groups. Additionally, the patients who chose the educational intervention 
were just slightly older than those who did not (M = 40.58; SD = 16.47 versus  
M =39.42; SD = 15.53) (Table 2).  
Another tool used by the psychiatrist to assess the patient at the time seen 
is the global assessment of functioning (GAF). This is a hypothetical continuum 
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Table 1. Frequency of the diagnosis in the sample 
 
 Disorganized Paranoid Affective Undifferentiated Residual Total 
 
Educated 
 
Not 
Educated 
 
Total  
 
Percent of  
Total 
 
         1 
 
 
         0 
 
         1 
 
 
     0.2% 
 
      79 
 
 
     155 
 
     234 
 
 
      51% 
 
       58 
 
 
       53 
 
     111 
 
 
      24% 
 
          36 
 
 
          77 
 
        113 
 
 
         24% 
 
       0 
 
 
       3 
 
       3 
 
 
    0.7% 
 
       173 
 
 
       289 
 
       462 
 
            
     99.9% 
 
 
Table 2. Age of the sample 
 
 N (Patients) Mean (Age) SD 
 
Educated 
 
Not Educated 
 
Total 
 
173 
 
289 
 
462 
 
40.58 
 
39.42 
 
16.47 
 
15.53 
 
ranging from 0 to 100 points and considers dangerousness, impairment in 
judgment, behavior influenced by delusions or hallucinations, and degrees of 
social, occupational or school functioning (DSM-IV, 2000). It is for reporting the 
clinician’s judgment of the individual’s overall level of functioning at the time 
seen and can vary from day to day.  
There was no significant difference in the GAF between the groups  
(M = 15.81; SD 16.97); however, 43% (n =197) of the admissions were missing 
scores (Figure 1). Unlike today, at the time the study began, the GAF was not 
required to be recorded as part of the diagnosis at the time of admission. Also, it is 
not surprising that the larger number of scores are between 10 and 20 since these 
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Figure 1. Global assessment of functioning for the sample 
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scores also mirror one aspect of the criteria for an involuntary psychiatric 
admission Such scores denote danger to self or others, either persistent danger 
(score of 1 to 10) or some danger (score of 11 to 20). Missing scores are recorded 
as 0 on the scale. 
There was also no difference in the GAF scores between males and 
females. This finding was contrary to the study by Atalay and Atalay (2006) that 
found that female patients scored higher than males on the GAF scale. Regardless, 
on all variables, the findings show that the groups are remarkably similar. 
Findings 
Research Question 1: Relapse Rates 
The two groups were compared to answer the first research question:  
Do patients with chronic schizophrenia who receive psychosocial education have 
lower relapse rates (recidivism) than those who do not receive psychosocial 
education? 
It is an accepted fact that the disease process of schizophrenia is likely to produce 
recurrent psychotic episodes regardless of the patient’s compliance (Geller, 1986; 
Lacro et al. 2002; Prince, 2004). Indeed, from the sample (n = 462), there were a 
total of 42 (9.1%) of patients who had more than one admission during the period 
of July 1, 1997 to June 30,1998. Of these 42, eleven (4 females, 7 males) received 
the educational intervention and 31 (9 females, 22 males) elected to not 
participate in the educational intervention. Interestingly, there were 47 (27%) 
from the original group of 173 who had chosen the educational intervention who 
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never returned to the hospital. Of these, there were 62 (40%) females and 93 
(60%) males. 
Following the study year, the return rate for the both groups of patients 
was tracked over the eight year period and if they returned, the number of days 
was counted. In July 1, 1998-June 30, 1999, 33 (19%) of the patients from the 
intervention group returned while 207 (72%) of the control patients returned. The 
1999-2000, groups had 62 (36%) of the intervention patients versus 145 (50%) of 
the control patients to return. In 2000-2001, 36 (21%) from the intervention group 
returned while 124 (43%) of the control group returned. The 2001-2002 period 
had 44 (25%) patients from the intervention group versus 127 (44%) patients from 
the control group to return. In 2002-2003, 29 (17%) of the patients from the 
intervention group returned while 127 (44%) of the control patients returned. In 
2003-2004, 27 (16%) of the intervention patients returned versus 88 (30%) of the 
control group patients returned. The 2004-2005, there were 40 (23%) patients 
from the intervention group who returned while 118 (41%) of the patients from 
the control group returned.  In 2005-2006, 44 (25%) of the patients from the 
intervention group returned while 115 (40%) patients from the control group 
returned (Figure 2).   
The data for the study were gathered retrospectively from aggregated 
statistics compiled by the facility for Quality Improvement activities. Individual 
patient identity and tracking was not the focus of the facility’s purpose for the 
data. Patients who had multiple readmissions, as most of these did, were 
repeatedly counted across the study years which made data analysis using 
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Figure 2. Recidivism by percentages educated and not educated groups 
     July 1, 1998-June 30, 2006 
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inferential statistics such as t test or ANOVA inappropriate. Therefore, descriptive 
statistics were used to interpret the data for answering the research questions 
about the recidivism rate for the patients.  
 There were actually only 126 patients from the study group of 173 who 
returned for admission over the 8-year period, but they had a return rate of 315. 
The percentage rate of return for the patients across the years ranged from a low 
of 15.6% to the highest of 35.4%. The control group had only 134 of the 289 who 
returned for admission, but their return rate was 1,021. The percentage rate for the 
control group ranged from the lowest of 31% to the highest of 71.6%. 
Consequently, the recidivism rate noted in both the percentage and number of 
patients for the control group was higher than for the intervention group. 
Research Question 2: Length of Stay 
The total number of inpatient days for each group was divided by the 
number of patients in each group to obtain the average length of stay (LOS) to 
answer the second research question: Is there a difference between the length of 
stay for readmitted patients with chronic schizophrenia who have participated in 
the psychosocial education and those who have not? 
For 1997-1998, the first year of the study, the intervention group (n = 173) 
and the control group (n = 289) showed only small differences in the LOS 
between those who received educational intervention (M = 61.50; SD 1.23) and 
those who did not (M = 67.00; SD 0.87) (Table 3).  The two groups were then 
compared the next 8 years.  
Tracking readmissions over the eight year period, the average length of 
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Table 3 
 
Length of stay for the sample 1997 – 1998 
 
 N  
(Patients) 
Mean  
(Number of days) 
SD 
 
Educated 
 
Not Educated 
 
Total in Sample 
 
173 
 
289 
 
462 
 
61.50 
 
67.00 
 
1.23 
 
0.87 
 
 
stay for the 28 patients from the group who had the educational intervention from 
July 1, 1998- June 30, 1999, was 68 days while the not educated patient group of 
195 had 54 days. The 1999-2000 year was 34 days for the 58 patients from the 
group who chose the educational groups and 38 days for the 139 patients who did 
not choose the intervention. The 2000-2001 patient educational group of 33 
members had 50 days while the not education group of 119 patients had 42 days. 
The 2001-2002 year was 29 days for the 42 patients from the group who chose the 
educational groups and 40 days for the 123 patients who did not choose the 
intervention. The 2002-2003 year was 21 days for the 28 patients from the group 
who chose the educational groups and 19 days for the 122 patients who did not 
choose the intervention. The 2003-2004 year was 33 days for the 25 patients from 
the group who chose the educational groups and 22 days for the 87 patients who 
did not choose the intervention. The 2004-2005 year was 20 days for the 39 
patients from the group who chose the educational groups and 31 days for the 116 
patients who did not choose the intervention. The 2005-2006 year was 20 days for 
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the 43 patients from the group who chose the educational groups and 20 days for 
the 113 patients who did not choose the intervention (Figure 4).  
As noted there were 40 intervention group patients and 155 of the control 
group who never returned after their initial admission. This made the number of 
patients to be followed: intervention group (n=126 of 173) and the control group 
(n=134 of 289). However, due to the retrospective nature of the study and the 
aggregated data available to the researcher from the study facility, individual 
patients were unable to be tracked. The multiple numbers of admissions for these 
remaining patients led to the total number of patients in the data over the 8 years 
to be inflated to a total of 296 to 315 patients for the intervention group and 1,014 
to 1,021 patients for the control group. These overlapping admissions for 
individual patients across the years prohibited data analysis using inferential 
statistics; therefore, descriptive statistics were used to interpret these data. 
There were a total of 74 patients over the eight year period primarily from 
the educational intervention group who had LOS of one year or more. These 
included 15 patients from July 1, 1998-June 30, 1999, 17 patients from 1999-
2000, 8 patients from 2000-2001, 11 patients from 2001-2002, 10 patients from 
2002-2003, 6 patients from 2003-2004, 6 patients from 2004-2005, and 1 patient 
from 2005-2006. These overlapping LOS from year to year led to significant 
spikes in the patient LOS in several of the years.  
The average LOS for the intervention group for 4 of the 8 years was 
greater than the control group.  In 1998-1999, the patients stayed 14 more days; 
2000-2001, the patients stayed 8 days longer; 2002-2003, their stay was 2 days 
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longer; and 2003-2004, the stay was 11 days longer. In 2005-2006, both groups 
stayed the same number of days (20). The control group had 3 years with longer 
stays. They were 1999-2000 with 4 days; 2001-2002 with 11 days; and 2004-2005 
also with 11 days. Thus, these and other external variables that were unable to be 
controlled for led the intervention group to have 35 more days than the control 
group.  
Another factor affecting the LOS for these patients could have been in 
response to changes made in the funding to the state psychiatric facilities through 
the managed care and TennCare programs after 1999. These changes affected the 
funding available for discharge placement and caused small groups of patients to 
have very high numbers of inpatient days that crossed over multiple years of the 
study. There was also an increased number of patients in the data over the 8 years 
to total 296 to 315 for the intervention group and 1,014 to1,021 for the control 
group. These overlapping admissions for individual patients across the years 
prohibited data analysis using inferential statistics; therefore, descriptive statistics 
were used to interpret these data. 
There were a total of 74 patients over the eight year period primarily from 
the educational intervention group who had LOS of one year or more. These 
included 15 patients from July 1, 1998-June 30, 1999, 17 patients from 1999-
2000, 8 patients from 2000-2001, 11 patients from 2001-2002, 10 patients from 
2002-2003, 6 patients from 2003-2004, 6 patients from 2004-2005, and 1 patient 
from 2005-2006. These overlapping LOS from year to year led to significant 
spikes in the patient LOS in several of the years.  
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The average LOS for the intervention group for 4 of the 8 years was 
greater than the control group.  In 1998-1999, the patients stayed 14 more days; 
2000-2001, the patients stayed 8 days longer; 2002-2003, their stay was 2 days 
longer; and 2003-2004, the stay was 11 days longer. In 2005-2006, both groups 
stayed the same number of days (20). The control group had 3 years with longer 
stays. They were 1999-2000 with 4 days; 2001-2002 with 11 days; and 2004-2005 
also with 11 days. Thus, these and other external variables that were unable to be 
controlled for led the intervention group to have 35 more days than the control 
group.  
 Another factor affecting LOS for these patients could have been in 
response to Changes made in the funding to the state psychiatric facilities through 
the managed care and TennCare programs after 1999. These changes affected the 
funding available for discharge placement and caused small groups of patients to 
have very high numbers of inpatient days that crossed over multiple years of the 
study. There was also an increased use of the newer classes of medication 
introduced after the year 2000, by psychiatrists in the state facility that may also 
have had an impact on the LOS for some patients. 
Research Question 3: Interval between Admissions 
The two groups were then compared with respect to the intervals from 
discharge to the next admission over the next 8 years to answer the third research 
question:  Is there a difference in the length of intervals between admissions for 
the group who had psychosocial education and the group who did not? 
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During the period of 1997-1998, of the 462 patients in the sample, there 
were 173 patients in the intervention group, and 289 patients in the control group. 
For the patients in this year, the interval between admissions for those who had 
the educational intervention was 18 days while the interval for the patients from 
the control group was 10 days.  (See Figure 3.) 
In the group of patients in the July 1, 1998-June 30, 1999, the interval 
from discharge to readmission was 217 days for the intervention group versus 50 
days for those in the control group. For the period of 1999-2000, the interval was 
236 days for the intervention group versus 74 days for the control group. In 2000-
2001, the interval from discharge to readmission was 256 days for the 
intervention group versus 110 days for the control group. The interval for the 
years of 2001-2002, was 367 days for the intervention group versus 169 days for 
the control group. The 2002-2003, interval between discharge and readmission 
was 346 days for the intervention group and170 days for the control group. In the 
years of 2003-2004, the interval for the intervention group was 431 days while the 
control group had 233 days. The interval for the years of 2004-2005 was 445 days 
for the intervention group and 274 days for the control group. In 2005-2006, the  
interval was 448 days for the intervention group while the control group interval 
was 259 days (Figure 4).  
The 126 patients remaining from the 173 from the intervention group and 
the 134 of the 289 from the control group through multiple readmissions across 
the 8 years of the study made the number of patients to be considered for the 
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Figure 3. Average length of stay by educated and not educated groups 
                July 1, 1998-June 30, 2006 
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Figure 4. Interval between admissions for educated and not educated groups 
        July 1, 1998-June 30, 2006 
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 interval computations rise to 296 for the intervention group and 1,014 for the 
control group. Since the data for the study were gathered retrospectively from 
aggregated statistics compiled by the facility for Quality Improvement activities, 
individual patient identity and tracking was not done. Most patients had multiple 
readmissions and were repeatedly counted across the study years. It was this 
phenomenon that made the use of inferential statistics inappropriate to analyze 
these data. Therefore, the graph was used to describe the difference in the interval 
data between the two groups. It clearly demonstrated that the difference between 
the two groups was remarkable. The patients in the intervention group had 
intervals between their last discharge to the next admission of 146 to 198 days 
longer than the control group. 
Summary 
 The 462 study participants included 279 males and 183 females with the 
diagnosis of schizophrenia who had an average age of 40 years. From these 
patients, 173 participated in patient education classes and 289 elected to not 
participate. The recidivism rate in both the percentage and number of patients for 
the control group was higher than for the intervention group. Due to uncontrolled-
for confounding variables, the differences between the two groups were not as 
clearly defined. In fact, in 4 of the 8 years, the intervention group had slightly 
longer lengths of stay. However, the research did show the value of patient 
education in positively impacting the intervals between readmissions for the two 
groups over the 8 years that were examined. 
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Chapter 5 
Findings, Conclusions, and Recommendations  
Summary 
Many studies have suggested that a better-informed patient can be more 
self-reliant after hospitalization which may increase compliance and reduce the 
rate of readmission. Shaffer and Lopes (2003) note that adherence is a learned 
behavior and can be improved with specific strategies directed toward improving 
adherence to the therapeutic regimen, practice by the patient, and reinforcement 
by healthcare providers. Of the research done on the effects of patient education, 
few specifically target the patient with schizophrenia for study. Schizophrenia is a 
serious mental health problem that affects roughly 1% of the population and has a 
nonadherence rate of close to 50% (Lacro et al. 2002). This has profound 
implications for our society, both in terms of human suffering and in prolonged 
and devastating financial costs (Horgan, 1990). Thus, the purpose of this study 
was to determine the effect that participation in patient psychosocial education 
activities while hospitalized has on readmission rates among patients with chronic 
schizophrenia.  
The study was a retrospective design using data from a medium sized state 
mental hospital. Data were accessed over a nine year period (July 1, 1997 to June 
30, 2006). It compared the readmission rate of patients with chronic schizophrenia 
who did and did not participate in psychosocial education activities to see if 
patient education made a difference in either the readmission rates, interval 
between admissions, or length of stay for this diagnostic group. 
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The research questions for the study were: 
1. Do patients with chronic schizophrenia who receive psychosocial       
education have lower relapse rates (recidivism) than those who do not 
receive psychosocial  education? 
           2.    Is there a difference between the length of stay for readmitted  
      patients with chronic schizophrenia who have participated in the 
      psychosocial education  and those who have not?             
3.    Is there a difference in the length of intervals between admissions for 
       the group who had psychosocial education and the group who did not?      
The convenience sample of adult patients was selected from a 12-month 
period (July 1, 1997 to June 30, 1998) using the 1,526 admissions to the Acute 
Care Program of the 172 bed state psychiatric facility. There were 462 adults with 
the target diagnoses included in the sample. On admission, the patients are 
assigned to patient education groups by their respective treatment teams and 
although participation in educational classes is expected as part of treatment, 
patients have the right to refuse. It was from these patients that the two 
intervention groups were formed – those who participated in the educational 
classes and those who elected to not participate.  
The data for the study were gathered retrospectively from aggregated 
statistics compiled by the facility for Quality Improvement activities. Individual 
patient identity and tracking was not the focus of the facility’s purpose for the 
data. So, patients who had multiple readmissions, as most of these did, were 
repeatedly counted across the study years. Considering that there were 40 patients 
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from the intervention group and 155 of the control group who had no return 
admissions, the study only tracked 126 from the intervention group and 134 from 
the control group over the remaining 8 years. However, the repeated relapses with 
rehospitalization for these remaining patients made the patient count 315 for the 
intervention group and 1,021 for the control group. The data collection nature of 
these data made data analysis using inferential statistics such as t test or ANOVA 
inappropriate. Therefore, descriptive statistics were used to interpret the data for 
answering the research questions about recidivism, LOS, and interval between 
admissions. 
Findings 
The intervention groups included 279 males (60%) and 183 females 
(40%). Those who chose the educational groups were slightly older than those 
who did not (M = 40.6; SD 16.5 versus M = 39.4; SD 15.5). There were more 
males than females in the study since the diagnosis of schizophrenia is more 
typical for males of this population while females are more likely to be given 
diagnoses of depressive or other types of psychotic disorders (Harrow et al. 2005). 
Nevertheless, Chi Square analysis found that there was no significant difference 
between the groups (X² = 3.11; df =1; p> 0.05). 
The intervention group consisted of these types of schizophrenia: 
Disorganized-1 (.2%), residual-3 (.7%), affective-111 (24%), undifferentiated-113 
(24%), and paranoid-243 (51%). None of the residual type and only one person 
from the disorganized type participated in the educational groups. This could be 
because although these disorders are absent of delusions or hallucinations, they 
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are more likely to have disorganized speech and behavior (DSM-IV, 2000). The 
paranoid type were the largest diagnostic group represented in the educational 
intervention group (n = 56), followed by affective (n = 38), and undifferentiated 
(n = 30). They are the also the diagnostic groups to most likely to have GAF 
scores below 20. These patients are plagued by delusions or hallucinations, but 
organized in their thinking and behavior. Additionally, most patients in these 
diagnostic categories are usually very bright intellectually.  
The global assessment of functioning (GAF), a scale from 0-100 that is 
used by the psychiatrist to assess the patient’s symptom severity, dangerousness, 
and functioning level at the time of admission. Contrary to an earlier study which 
found that female patients scored higher than males on the GAF scale (Atalay and 
Atalay, 2006), this study found no difference in the GAF scores between males 
and females.  Although it is used as a standard in the admission diagnosis for 
involuntary admissions to the psychiatric hospital today, the GAF was not 
required at the time of this study. Of the 462 study patients, only 197 (43%) of 
them had their admission GAF scores recorded. Regardless, on all variables, the 
findings show that the groups are very similar. 
The first research question asked: Do patients with chronic schizophrenia 
who receive psychosocial education have lower relapse rates (recidivism) than 
those who do not receive psychosocial education? 
To answer this question, the patients from the 1997-1998 original sample 
were reviewed. It was found that there were 47 (27%) from the group of 173 who 
chose the educational intervention and 155 (54%) from the group of 289 who 
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elected not to participate in the educational intervention who did not return to the 
hospital after their initial admission. The intervention group included 19 (40%) 
females and 28 (60%) males while the control group had 62 (40%) females and 93 
(60%) males. 
Following the study year, the return rate for both groups was tracked and 
if the patients were readmitted, the number of days was counted to see if there 
was a difference between the two groups. It was found that both the number of 
patients and return rate for the years following the initial intervention was 
considerably lower for patients who had the educational intervention (M = 37.0; 
SD 3.84) than those in the control group (M = 126.8; SD 11.01).  
The length of stay (LOS) was the focus of the second research question: Is 
there a difference between the length of stay for readmitted patients with chronic 
schizophrenia who have participated in the psychosocial education and those who 
have not? 
For this determination, when the patients were readmitted, the total 
number of inpatient days for each group was divided by the number of patients in 
each group to obtain their average LOS. In the first year if the study, the two 
groups had very similar LOS between the two groups-educational group (M = 
61.5; SD 1.23) and control group (M = 67.0; SD 0.87).  
In 4 of the 8 years of the study (1998-1999, 1999-2000; 2000-2001, and 
2003-2004), there were 74 patients, many in the educational group, who had LOS 
of one year or more. In fact, several patients had longer than 500-day stays during 
their one admission that crossed over more than one fiscal year during the study. 
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This phenomenon caused those from the educational intervention group to stay 
longer than the control group. 
The slight increase in these LOS was most likely due to funding changes 
for the state hospitals that occurred with the change from Medicaid to TennCare 
in the late 1990s and the advent of new managed care contracts. These changes 
caused small numbers of patients with discharge placement issues to have very 
high numbers of inpatient days. However, the remaining years showed no 
remarkable differences between the number of days in the hospital for either of 
the groups. 
The final research question asked: Is there a difference in the length of 
intervals between admissions for the group who had psychosocial education and 
the group who did not? 
To answer this question, the length of the interval between admissions for 
the two groups was compared. The time from the last discharge to the next 
admission was counted annually for each patient for each year. It was noted that 
in 1997-1998, the two groups were very close with the intervention group having 
18 days between the last discharge and next admission while the control group 
only had 10 days. However, over the remaining years of the study, the educational 
intervention greatly outdistanced the control group by having much longer periods 
from discharge to the next admission. The difference was between 146 to198 
days. 
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Discussion 
 In relation to the existing literature presented in Chapter 2, schizophrenia 
is among the diagnoses most likely to produce recurrent psychotic episodes and 
accounts for a large portion of all long-stay hospital days (Citrome, 2004; 
Kleyman & Rozenfeld, 2001; Surber et al. 1987). The study validated the findings 
of these various researchers since when relapse did occur, many of these patients 
did have an increased length of stay. The findings were also consistent with those 
of Stenberg et al. (1998) who found that the educational modules developed by 
Liberman et al. (1986) had little effect on the number of readmissions, but did 
have an effect on their duration.  
A limitation of the study is that these data are entirely from the admissions 
of a single state psychiatric hospital. So, an uncontrolled variable that must be 
considered is if the patient needs hospitalization that s/he may go somewhere else. 
Indeed, Swett (1995) notes that any study of readmission must take into account 
the possibility that the patient might be readmitted to another hospital. Although 
there is no guarantee that this may not have occurred in this study, given the 
paucity of most of their resources and the severity of most of the patient’s 
symptoms, unless they travel out of this area, they are likely to be admitted to the 
state hospital rather than a private facility in the city.  
Other limitations to the study that possibly affected the basic premise of 
the research questions must be considered. First, during the 8 year period, there 
were changes in healthcare funding for the state psychiatric hospitals that 
increased some patient LOS since viable placement options disappeared. Then, 
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there were changes in practice by psychiatrists to the use of the newer atypical 
antipsychotic drugs that are more efficacious, which may have also affected the 
LOS. There was inconsistent recording of GAF scores on admission in 1997-
1998, which resulted in 43% of the scores to be missing. Moreover, given the 
subjective nature of the criteria, the interpretation of the diagnostic criteria for the 
different types of schizophrenia by different practitioners may have changed over 
time. 
Consideration must be given to the fact that although the educational 
groups were an expectation as part of treatment; the patients could refuse to 
participate. The voluntary nature of participation brings into question the 
motivation of those who did participate. The patients with the diagnosis of 
paranoid type were largest group who participated in the educational groups. It is 
uncertain whether they were more receptive to training, had authority issues, or 
were just worried about what might be said (about them) in the groups. The 
educational level of the sample was not included in the demographics and 
receptivity to learning was not a question for this study. However, more females 
than males were in the intervention group leading to questions about gender 
expectations, conformity, and desire to please the staff. 
Intervening factors that might affect the study are the educational classes 
themselves. Although there were structured topics for the educational groups, 
there were multiple instructors for the classes making it difficult to assure either 
the quality of the educational instruction or the content for the sample. Also, the 
ability of the patients to choose not to participate in the assigned groups could 
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have biased the sample. Similarly, the type patient who actually participated may 
have been biased to one diagnostic group or another. 
Finally, since this was a retrospective study using a convenience sample 
and diagnoses limited to patients with schizophrenia, these findings might be 
meaningful only to these groups of patients. Although the study involved multiple 
years, the two groups were often unequal in size and had some extremes in some 
data sets (such as the LOS crossing multiple years). Thus, these external threats to 
validity may prohibit the generalization of the findings of this study.   
Conclusions 
Noncompliance is high across all areas of medicine (Pomerance, 2004) not 
just for the psychiatric patient. However, it is an accepted fact that the disease 
process of schizophrenia is likely to produce recurrent psychotic episodes 
regardless of the patient’s compliance (Geller, 1986; Lacro et al. 2002; Prince, 
2004). The findings for the 8 years examined determined that both the number of 
patients and return rate (recidivism) for the years following the initial intervention 
was considerably lower for patients who had the educational intervention and the 
patients who had the educational intervention had longer intervals between 
admissions. However, due to uncontrolled-for confounding variables, the average 
LOS for the intervention group for 4 of the 8 years was greater than the control 
group.  
 Knowledge is power and education is the key to the knowledge that gives 
the patient some control over their illness. It is a cost-effective measure that 
improves outcomes, adherence to the treatment plan (Shaffer & Lopes, 2003), and 
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disrupts the “revolving door” phenomenon among the mentally ill (Haywood et 
al. 1995). Presenting patients the opportunity to make choices in their treatment, 
enables them to reach their full potential in spite of their mental illness. Therefore, 
the challenge for healthcare providers is to empower the patient to be more self-
reliant in the quest for their individual recovery. 
Recommendations 
The findings of this study demonstrate the value of patient education to 
assist patients with improvement in self-management and compliance. Patients 
may elect to not participate in formal group educational activities for one reason 
or another. The following steps could be taken to assure that the patients more 
consistently participate: 
1. Use educational modules that are structured and focused toward skills 
training for the core groups. 
2. Allow patients to select educational groups/activities of interest from a 
menu of available educational opportunities with core educational 
groups such as medication management and symptom management 
being mandatory for patients. 
3. Privilege levels for patients while hospitalized could be tied to their 
participation in a certain number of psychosocial educational groups. 
4. Direct care staff must make patient education a priority by making a 
positive environment for educational opportunities and encouraging 
patient participation. 
5. Staff must be creative and make each contact with patients an 
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opportunity for presenting educational materials/concepts. 
Additionally, the area of patient education offers many opportunities for 
future research that the present study began. Future studies might be more 
conclusive with findings that better able to be generalized if:  
            1.  Readmissions to various hospitals and life changes that impact  
readmission (i.e.: having no further psychotic breaks, getting  
 
                  insurance, death, etc.) were more tightly controlled. 
2. The design included control for differences in both clinician practices 
and shospital policies and procedures. 
3. A prospective study was designed using similar groups with better-
controlled variables and consistent interventions for all patients. 
4. Factors that influence patients to participate in patient education were 
explored (i.e.: attitude toward authority, receptivity toward learning, 
desire for discharge, etc.). 
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Appendix C 
 
Global Assessment of Functioning 
 
 
Consider psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.  Do not 
include impairment in functioning due to physical (or environmental) limitations. 
Code (Note:  Use intermediate codes when appropriate, e.g., 45, 68, 72) 
100 Superior functioning in a wide range of activities, life’s problems never seem to get out of  
91 hand, is sought out by others because of his or her many positive qualities.  No symptoms. 
90 Absent or minimal symptoms (e.g., mild anxiety before an exam), good functioning in all  
 areas, interested and involved in a wide range of activities, socially effective, generally 
81 satisfied with life, no more than everyday problems or concerns (e.g., an occasional argument 
family members). 
80      If symptoms are present, they are transient and expectable reactions to psychosocial  
 stressors (e.g., difficulty concentrating after family argument); no more than slight 
71 impairment in social, occupational, or school functioning (e.g., temporarily falling behind 
in school work). 
70 Some mild symptoms (e.g., depressed mood and mild insomnia) OR some difficulty in social, 
 occupational, or school functioning (e.g., occasional truancy, or theft within the household),  
61 but generally functioning pretty well, has some meaningful interpersonal relationships. 
60 Moderate symptoms (e.g., flat affect and circumstantial speech, occasional panic attacks) 
 OR moderate difficulty in social, occupational, or school functioning (e.g., few friends, 
51 conflicts with peers or co-workers). 
50 Serious symptoms (e.g., suicidal ideation, severe obessional rituals, frequent shoplifting) 
 Or any serious impairment in social, occupational, or school functioning e.g., no  
41 friends, unable to keep a job). 
40 some impairment in reality testing or communication (e.g., speech is at times illogical,  
 obscure, or irrelevant) OR major impairment in several areas, such as work or school, 
31 family relations, judgment, thinking, or mood (e.g., depressed man avoids friends, neglects 
family, and is unable to work; child frequently beats up younger children, is defiant at home, 
and is failing in school). 
30 Behavior is considerably influenced by delusions or hallucinations OR serious impairment 
 in communication or judgment (e.g., sometimes incoherent, acts grossly inappropriately, 
21 suicidal preoccupation) OR inability to function in almost all areas (e.g., stays in bed all day; 
no job, home, or friends). 
20 Some danger of hurting self or others (e.g., suicide attempts without clear expectation of  
 of death; frequently violent; manic excitement) OR occasionally fails to maintain minimal 
11 personal hygiene (e.g., smears feces) OR gross impairment in communication (e.g., largely  
incoherent or mute). 
10 Persistent danger of severely hurting self or others (e.g., recurrent violence) OR persistent 
 inability to maintain minimal personal hygiene OR serious suicidal act with clear  
1 expectation of death. 
0 Inadequate information 
 
The rating of overall psychological functioning on a scale of 0-100 was operationalized by Luborsky in the Health-
Sickness Rating Scale (Luborsky L.: “Clinicians’ Judgments of Mental Health.”  Archives of General Psychiatry 7: 407-
417, 1962). Spitzer and colleagues developed a revision of the Health-Sickness Rating Scale called the Global Assessment 
Scale (GAS) (Ebducitt J. spitzer RL, Fleiss JL, Cohen J: “The Global Assessment Scale: A Procedure for Measuring 
Overall Severity of Psychiatric Disturbance.” Archives of General Psychiatry 33: 766-771, 1976).  A modified version of 
the GAS was included in DSM-III-R as the Global Assessment of Functioning (GAF) Scale. 
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders.  Fourth Edition, 
Text Revision.  Washington, D.C.: American Psychiatric Association. 
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Psychosocial Education Checksheet 
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